Alzheimer’s disease (Atypical or mixed), excluding more controls

AD_AM_EXMORE

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data
1. Apply sex-specific rule None	-
2. Check conditions None
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — F00.24, G30.8, G30.8+F00.20 Cause of death:* ICD-10 — F00.24*, G30.8, G30.8+F00.20 2 out of 7 registries used, show all original rules.	-
4. Check minimum number of events None	-
5. Include endpoints None	-
6. Filter based on genotype QC (FinnGen only) None	-

Control definitions (FinnGen only)

Control exclude: G6_AD_WIDE, F5_DEMENTIA, F5_DEMENTIA_U, F5_PSYCH, NEURODIS, MEMLOSS, TRAUMBRAIN_NONCONCUS

Extra metadata

First used in FinnGen datafreeze: DF2

NAME	AD_AM_EXMORE
CONTROL_EXCLUDE	G6_AD_WIDE\|F5_DEMENTIA\|F5_DEMENTIA_U\|F5_PSYCH\|NEURODIS\|MEMLOSS\|TRAUMBRAIN_NONCONCUS
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	F0024\|G308
HD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	F0024\|G308
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Alzheimer’s disease (Atypical or mixed), excluding more controls based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Alzheimer’s disease (Atypical or mixed)

Case counts by codes

↥

FinnGen case counts by registry codes:

No upset plot: script not run.

No upset table: script not run.

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	49324	30174	18896
Only index persons	44818	27767	17051
Unadjusted period prevalence (%)
Whole population	0.73	0.86	0.53
Only index persons	0.88	1.02	0.65
Median age at first event (years)
Whole population	83.60	84.60	82.06
Only index persons	83.87	84.83	82.31

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	3491	1503	1988
Unadjusted period prevalence (%)	0.72	0.51	0.88
Median age at first event (years)	81.80	82.22	81.48

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
2416: Matched controls
22974

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

N06DA02

ATC

donepezil; oral

489.7

323.0

944

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

253.0

323.0

472

N05AX08

ATC

risperidone; systemic

83.9

323.0

748

122

P20

ICPC

Memory disturbance

14.7

323.0

1108

1252

G30.1

ICD-10 Finland

Alzheimer disease with late onset

134.5

323.0

652

F03

ICD-10 Finland

Unspecified dementia

79.8

323.0

522

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

206.1

323.0

399

AA1AD

NOMESCO Finland

CT of head and brain

9.4

323.0

934

1445

307

Kela drug reimbursment

Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease

+∞

323.0

1010

F00.20

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type without additional symptoms

1736.6

323.0

444

N06DX01

ATC

memantine; oral

775.5

323.0

1375

N06DA04

ATC

galantamine; oral

735.4

323.0

391

N05AH04

ATC

quetiapine; oral

23.7

323.0

603

318

G30.8

ICD-10 Finland

Other Alzheimer disease

3152.3

323.0

1637

F00.20*G30.8

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type without additional symptoms

1071.7

323.0

1293

N06DA03

ATC

rivastigmine; oral, transdermal

1314.3

323.0

693

G30.9

ICD-10 Finland

Alzheimer disease, unspecified

1479.9

323.0

590

SPAT1053

SPAT

Memory test

6.6

322.2

1036

2347

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

13.9

283.3

520

443

P70

ICPC

Dementia

86.3

273.3

309

F00.10*G30.1

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms

121.7

269.5

293

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

75.3

243.9

281

R53

ICD-10 Finland

Malaise and fatigue

5.9

242.7

817

1837

S06.0

ICD-10 Finland

Concussion

34.1

211.6

283

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

4.3

210.8

1032

3369

SPAT1216

SPAT

Assessment of functional ability

5.0

197.6

759

1915

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

5.0

195.8

762

1947

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

17.7

193.8

317

194

A28

ICPC

Limited function/disability NOS

4.6

193.0

826

2325

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

6.8

192.5

542

932

N05BA04

ATC

oxazepam; oral

4.7

184.2

761

2050

N06AX11

ATC

mirtazapine; oral

4.5

183.1

811

2340

SPAT1245

SPAT

Provision of support and information to patient’s family members

10.6

181.2

377

395

SPAT1234

SPAT

Support of social functional capacity

9.5

165.6

366

425

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

+∞

157.1

152

N03AG01

ATC

valproic acid; systemic, rectal

97.1

153.0

171

SPAT1222

SPAT

Counselling/guidance promoting independent living

4.3

152.5

681

1927

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

6.8

150.2

416

681

F0029, G308

ICD-10 Finland

+∞

149.8

145

I63.3

ICD-10 Finland

Cerebral infarction due to thrombosis of cerebral arteries

1513.7

149.8

147

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

4.6

147.7

592

1500

F06.7

ICD-10 Finland

Mild cognitive disorder

27.6

147.6

208

N06AB10

ATC

escitalopram; oral

7.6

147.0

374

541

N02BE01

ATC

paracetamol; systemic, rectal

3.5

132.4

2013

13562

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

+∞

131.0

127

G30

ICD-10 Finland

Alzheimer disease

270.1

129.9

134

G47.3

ICD-10 Finland

Sleep apnoea

26.8

128.9

183

S06.5

ICD-10 Finland

Traumatic subdural haemorrhage

1250.9

126.9

125

SPAT1254

SPAT

Administration of medicine

4.0

126.4

595

1728

R41.0

ICD-10 Finland

Disorientation, unspecified

15.6

125.4

214

142

J18.9

ICD-10 Finland

Pneumonia, unspecified

3.0

124.9

1029

4570

F32.9

ICD-10 Finland

Depressive episode, unspecified

26.0

123.1

176

L28

ICPC

Limited function/disability (L)

3.6

115.6

622

2003

N05AH03

ATC

olanzapine; systemic

64.6

114.5

135

N04BA02

ATC

levodopa and decarboxylase inhibitor; oral

37.6

109.1

142

F05.1

ICD-10 Finland

Delirium superimposed on dementia

+∞

108.1

105

G45.1

ICD-10 Finland

Carotid artery syndrome (hemispheric)

1051.8

107.2

106

G91.2

ICD-10 Finland

Normal-pressure hydrocephalus

1031.0

105.1

104

SPAT1229

SPAT

Assessment of need for aid

5.1

103.7

364

777

F00.10

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms

498.5

100.3

101

SPAT1301

SPAT

No procedures

2.7

99.6

938

4368

G30.0

ICD-10 Finland

Alzheimer disease with early onset

488.1

98.3

N06AB04

ATC

citalopram; systemic

3.9

96.7

450

1262

A04

ICPC

Weakness/tiredness general

3.9

95.0

446

1259

G20

ICD-10 Finland

Parkinson disease

114.7

94.7

104

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

7.1

92.6

243

358

R41.3

ICD-10 Finland

Other amnesia

26.2

92.1

131

G40.9

ICD-10 Finland

Epilepsy, unspecified

896.9

91.7

F05.9

ICD-10 Finland

Delirium, unspecified

111.2

91.7

101

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

11.1

88.9

176

161

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

3.2

87.6

554

1965

F009, G309

ICD-10 Finland

+∞

86.4

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

3.4

85.8

494

1634

F00.00*G30.0

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, presenile onset without additional symptoms

+∞

85.3

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

3.7

85.2

427

1265

110

Kela drug reimbursment

Parkinson's disease and comparable movement disrorders

+∞

84.3

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

8.5

84.0

193

231

A06AD11

ATC

lactulose; oral

2.9

82.2

617

2445

R42

ICD-10 Finland

Dizziness and giddiness

2.9

81.9

606

2377

U04

ICPC

Incontinence urine

6.4

80.1

226

366

K90

ICPC

Stroke/cerebrovascular accident

41.2

78.5

100

G45.0

ICD-10 Finland

Vertebro-basilar artery syndrome

764.2

78.3

I63.4

ICD-10 Finland

Cerebral infarction due to embolism of cerebral arteries

+∞

75.0

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

35.1

72.9

W19

ICD-10 Finland

Unspecified fall

4.5

71.2

277

646

F01.9

ICD-10 Finland

Vascular dementia, unspecified

67.9

71.1

AAF05

NOMESCO Finland

Ventriculoperitoneal shunt

683.2

70.1

R55

ICD-10 Finland

Syncope and collapse

3.4

69.3

387

1234

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

6.7

68.7

186

284

F00.9

ICD-10 Finland

Dementia in Alzheimer disease, unspecified

653.0

67.0

S01.0

ICD-10 Finland

Open wound of scalp

4.6

66.4

248

554

SPAT1263

SPAT

Sampling

2.2

64.7

973

5430

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

3.0

64.2

436

1589

I95.1

ICD-10 Finland

Orthostatic hypotension

6.1

63.6

184

306

F0019, G301

ICD-10 Finland

+∞

62.6

SPAT1101

SPAT

Orthostatic test

4.6

62.0

232

518

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

2.4

61.5

673

3218

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

3.5

61.5

325

988

N05BA06

ATC

lorazepam; systemic, sublingual

5.5

61.2

193

357

C10AA01

ATC

simvastatin; oral

2.0

61.0

1348

8772

J01DB01

ATC

cefalexin; oral

2.1

59.5

1629

11502

N06AX16

ATC

venlafaxine; oral

7.0

58.5

151

215

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

2.2

58.0

773

4038

R56.8

ICD-10 Finland

Other and unspecified convulsions

10.8

57.7

115

106

G40.22

ICD-10 Finland

Complex partial epileptic seizure with secondary generalization

+∞

57.4

WYA20

NOMESCO Finland

Home visit

18.3

57.4

N06AX26

ATC

vortioxetine; oral

16.3

56.8

G31.8

ICD-10 Finland

Other specified degenerative diseases of nervous system

188.1

55.1

TAB00

NOMESCO Finland

Lumbar puncture

17.7

54.9

SPAT1252

SPAT

Overall medication plan or its review

3.6

54.6

268

764

SPAT1304

SPAT

Counselling and guidance related to ageing

3.0

54.4

351

1224

SPAT1360

SPAT

Extensive global examination

3.7

54.3

257

711

SPAT1231

SPAT

Assessment of adjustments needed in living environment

9.2

53.5

116

125

N30.0

ICD-10 Finland

Acute cystitis

2.9

53.4

365

1321

G56.0

ICD-10 Finland

Carpal tunnel syndrome

9.7

53.4

112

114

G40.29

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

+∞

51.3

G72.8

ICD-10 Finland

Other specified myopathies

493.0

50.6

F00.24

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type other additional symptoms of mixed type

+∞

50.2

S70.0

ICD-10 Finland

Contusion of hip

5.8

49.9

150

261

I65.2

ICD-10 Finland

Occlusion and stenosis of carotid artery

61.6

48.3

N18

ICPC

Paralysis/weakness

23.2

47.3

SPAT1305

SPAT

Counselling and guidance related to physical exercise

3.2

46.6

275

898

N02AA05

ATC

oxycodone; systemic

2.3

46.5

503

2343

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

2.0

45.8

763

4291

Z75.5

ICD-10 Finland

Holiday relief care

20.4

45.4

I61.0

ICD-10 Finland

Intracerebral haemorrhage in hemisphere, subcortical

+∞

45.1

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

3.9

45.1

197

507

F29

ICD-10 Finland

Unspecified nonorganic psychosis

155.0

45.0

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

2.5

44.9

416

1787

XA800

NOMESCO Finland

Neuropsychological investigation

41.8

44.4

I61.9

ICD-10 Finland

Intracerebral haemorrhage, unspecified

222.7

44.2

F0024, G308

ICD-10 Finland

+∞

44.1

I69.1

ICD-10 Finland

Sequelae of intracerebral haemorrhage

+∞

44.1

AAD10

NOMESCO Finland

Evacuation of chronic subdural haematoma

+∞

44.1

C03CA01

ATC

furosemide; systemic

1.8

44.0

1137

7470

SAD01

NOMESCO Finland

Assessment of need for oral health care, standard

3.5

42.8

216

626

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

9.6

42.8

S72.0

ICD-10 Finland

Fracture of neck of femur

3.7

42.7

198

536

PAF14

NOMESCO Finland

Thrombendarterectomy of internal carotid artery

212.8

42.2

F002, G308

ICD-10 Finland

+∞

42.0

E86

ICD-10 Finland

Volume depletion

6.2

41.8

117

186

SPAT1251

SPAT

Organisation of medication

4.6

41.7

153

333

SPAT1172

SPAT

Guidance concerning hydration

5.5

41.6

130

237

130

Kela drug reimbursment

Malignant tumour

0.2

41.2

2079

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

8.5

41.1

108

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

141.9

41.0

I10

ICD-10 Finland

Essential (primary) hypertension

1.8

40.8

1519

11133

A10AE04

ATC

insulin glargine; parenteral

3.1

40.7

250

836

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.8

40.5

286

1047

N06AX21

ATC

duloxetine; oral

4.9

38.8

134

274

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

3.4

38.6

200

591

ACC59

NOMESCO Finland

Decompression and freeing of adhesions of peripheral nerve: other or unspecified

26.2

38.4

N05AD01

ATC

haloperidol; systemic

5.0

37.9

128

255

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

+∞

37.9

B01AC07

ATC

dipyridamole; systemic

3.2

37.6

214

679

N06AB06

ATC

sertraline; oral

5.0

37.5

125

246

B01AC04

ATC

clopidogrel; oral

2.2

37.5

468

2305

J01CA08

ATC

pivmecillinam; oral

1.9

37.4

691

3975

N05AB03

ATC

perphenazine; systemic, rectal

17.2

37.3

ACC51

NOMESCO Finland

Release of median nerve

60.8

37.3

N03AX14

ATC

levetiracetam; systemic

41.3

37.3

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.4

36.7

338

1439

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

2.2

36.5

452

2216

SPAT1262

SPAT

Handing over of treatment supplies

2.1

36.5

455

2236

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.8

35.2

801

4933

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.4

35.1

333

1435

I67.3

ICD-10 Finland

Progressive vascular leukoencephalopathy

22.5

34.8

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

7.0

34.1

122

F22.0

ICD-10 Finland

Delusional disorder

75.4

34.1

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

5.3

34.0

108

201

SPAT1246

SPAT

Screening of depression or other psychiatric problem

8.7

34.0

I63.1

ICD-10 Finland

Cerebral infarction due to embolism of precerebral arteries

+∞

33.8

F21

ICPC

13.3

33.7

I63.0

ICD-10 Finland

Cerebral infarction due to thrombosis of precerebral arteries

+∞

32.8

I62.0

ICD-10 Finland

Nontraumatic subdural haemorrhage

+∞

32.8

N28

ICPC

Limited function/disability (N)

23.9

32.7

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.9

32.7

637

3706

N87

ICPC

Parkinsonism

61.1

32.3

G04CA02

ATC

tamsulosin; oral

1.7

32.3

843

5388

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

33.8

32.0

S06.3

ICD-10 Finland

Focal brain injury

+∞

31.7

3472A

ICD-9 Finland

Cataplexy and narcolepsy[OBSTRUKTIIVINEN UNIAPNEA]

+∞

31.7

NA1AD

NOMESCO Finland

Cervical spine CT examination

6.5

31.2

124

NFB20

NOMESCO Finland

Primary partial prosthetic replacement of hip joint using cement, other or unspecified

4.1

31.1

126

302

SPAT1167

SPAT

Insertion of urinary catheter

3.7

31.1

144

389

F0009, G300

ICD-10 Finland

+∞

30.7

F00

ICD-10 Finland

Dementia in Alzheimer disease

300.9

30.3

J01EA01

ATC

trimethoprim; systemic

1.8

29.9

584

3382

A29

ICPC

General symptom/complaint other

2.4

29.8

276

1169

4340A

ICD-9 Finland

Occlusion of cerebral arteries, Cerebral thrombosis

+∞

29.7

C07AB07

ATC

bisoprolol; oral

1.6

29.3

1278

9364

SPAT1215

SPAT

Assessment of need for medical rehabilitation

4.8

28.9

201

G25.9

ICD-10 Finland

Extrapyramidal and movement disorder, unspecified

54.6

28.5

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

7.1

28.3

SPAT1249

SPAT

Treatment-related counselling outside office

1.7

28.1

763

4889

G25.8

ICD-10 Finland

Other specified extrapyramidal and movement disorders

+∞

27.6

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

+∞

27.6

Z02.4

ICD-10 Finland

Examination for driving licence

0.5

27.6

279

4688

N03AF02

ATC

oxcarbazepine; oral

18.1

27.5

R33

ICD-10 Finland

Retention of urine

2.2

27.4

312

1457

H25.1

ICD-10 Finland

Senile nuclear cataract

1.6

27.2

984

6810

F05.8

ICD-10 Finland

Other delirium

139.4

27.1

G45.4

ICD-10 Finland

Transient global amnesia

31.5

27.1

SPAT1050

SPAT

Extensive neurological examination

6.3

27.1

115

F32.1

ICD-10 Finland

Moderate depressive episode

40.9

27.1

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.7

27.0

776

5037

NF1AA

NOMESCO Finland

Hip X-ray examination

2.4

27.0

246

1034

L89

ICD-10 Finland

Decubitus ulcer and pressure area

6.4

27.0

112

E0000UV

ATC

1.7

26.9

721

4588

SPAT1148

SPAT

Treatment of chronic ulcer or burn

2.0

26.8

373

1896

K91

ICPC

Cerebrovascular disease

45.4

26.8

G40.2

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

+∞

26.6

35399

ICD-8 Finland

Sciatica

+∞

26.6

SPAT1139

SPAT

Nutrition survey

4.5

26.6

215

N29

ICPC

Neurological sympt/complt other

12.6

26.5

J01MA02

ATC

ciprofloxacin; systemic

1.6

26.4

903

6139

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)

1.6

26.3

989

6896

X59

ICD-10 Finland

Exposure to unspecified factor

2.2

26.1

294

1365

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

2.3

26.0

264

1166

C09AA05

ATC

ramipril; oral

1.7

26.0

710

4534

B01AA03

ATC

warfarin; systemic

1.7

25.9

744

4820

SPAT1279

SPAT

Preparation of immediate hospitalisation

6.7

25.9

AA5BD

NOMESCO Finland

CT of cerebral ischaemia

32.7

25.8

A01

ICPC

Pain general/multiple sites

2.9

25.7

166

571

N05CF01

ATC

zopiclone; oral

1.7

25.6

755

4922

F00.2

ICD-10 Finland

Dementia in Alzheimer disease, atypical or mixed type

+∞

25.6

SPAT1307

SPAT

Psychosocial counselling and guidance

7.0

25.4

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

5.1

25.3

157

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.6

25.2

960

6693

N05AD03

ATC

melperone; systemic

10.8

24.7

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

+∞

24.6

I69.0

ICD-10 Finland

Sequelae of subarachnoid haemorrhage

+∞

24.6

F0021, G308

ICD-10 Finland

+∞

24.6

85000

ICD-8 Finland

Concussion, Current or unspecified

+∞

24.6

F00.00

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, presenile onset without additional symptoms

+∞

24.6

N30.9

ICD-10 Finland

Cystitis, unspecified

3.1

24.1

138

438

N99

ICPC

Neurological disease other

22.5

24.1

R50.9

ICD-10 Finland

Fever, unspecified

2.1

24.0

312

1540

SPAT1260

SPAT

Consultation of another employee

1.9

23.7

370

1960

A10BA02

ATC

metformin; oral

1.7

23.7

686

4429

F02.39*G20

ICD-10 Finland

Dementia in Parkinson's disease without information on additional symptoms

+∞

23.5

F05.0

ICD-10 Finland

Delirium not superimposed on dementia, so described

+∞

23.5

G91.0

ICD-10 Finland

Communicating hydrocephalus

+∞

23.5

C08CA01

ATC

amlodipine; oral

1.6

23.5

906

6304

I67.9

ICD-10 Finland

Cerebrovascular disease, unspecified

64.7

23.3

E000001

ATC

1.9

23.2

385

2087

N03AF01

ATC

carbamazepine; oral, rectal

4.2

23.1

214

SPAT1240

SPAT

Therapeutic discussion

4.0

23.0

228

C10AA05

ATC

atorvastatin; oral

1.6

23.0

854

5877

F01.20

ICD-10 Finland

Subcortical vascular dementia without additional symptoms

22.7

22.8

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.6

22.8

862

5953

Z02.7

ICD-10 Finland

Issue of medical certificate

3.0

22.5

135

443

F0022, G308

ICD-10 Finland

+∞

22.5

G40.20

ICD-10 Finland

Complex partial seizures with only alteration of consciousness

+∞

22.5

F0014, G301

ICD-10 Finland

+∞

22.5

F0023, G308

ICD-10 Finland

+∞

22.5

F00.14

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, senile onset other additional symptoms of mixed type

+∞

22.5

R26.8

ICD-10 Finland

Other and unspecified abnormalities of gait and mobility

7.2

22.4

B03BA03

ATC

hydroxocobalamin; parenteral

2.3

22.4

213

911

R1250

NOMESCO Finland

Evaluation of functional capability

7.7

22.3

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

220.5

22.2

SAB01

NOMESCO Finland

Restricted oral and dental health check by dental hygienist or dental assistant

3.1

22.2

129

415

A98

ICPC

Health maint/preventive medicine

1.6

22.1

1733

14163

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.6

22.1

873

6083

SPAT1296

SPAT

Other function in accordance with occupational therapy nomenclature

10.6

22.1

I50.9

ICD-10 Finland

Heart failure, unspecified

1.7

21.9

547

3373

F32

ICD-10 Finland

Depressive episode

6.9

21.8

R51.80

ICD-10 Finland

Headache

2.8

21.7

147

519

NE1AA

NOMESCO Finland

Pelvis X-ray examination

2.4

21.6

189

774

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

3.0

21.6

133

442

H02AB02

ATC

dexamethasone; systemic

0.3

21.5

1451

G44.2

ICD-10 Finland

Tension-type headache

3.2

21.0

114

350

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.6

20.9

801

5522

T36

ICD-10 Finland

Poisoning by systemic antibiotics

11.4

20.8

P29

ICPC

Psychological sympt/compl other

8.1

20.8

J01CA04

ATC

amoxicillin; systemic

1.5

20.8

1441

11356

Z01.8

ICD-10 Finland

Other specified special examinations

1.8

20.6

366

2024

N40

ICD-10 Finland

Hyperplasia of prostate

1.6

20.5

752

5120

N05AH02

ATC

clozapine; systemic

+∞

20.5

I60.9

ICD-10 Finland

Subarachnoid haemorrhage, unspecified

+∞

20.5

A02BC02

ATC

pantoprazole; systemic

1.5

20.4

1270

9760

A10AE05

ATC

insulin detemir; parenteral

3.0

20.4

124

412

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

3.9

20.3

212

H02AA02

ATC

fludrocortisone; oral

10.7

20.2

I69.8

ICD-10 Finland

Sequelae of other and unspecified cerebrovascular diseases

201.2

20.2

A06AC01

ATC

ispaghula (psylla seeds); oral

1.7

20.0

497

3052

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.9

19.9

300

1561

A69

ICPC

General and Unspecified, Other reason for encounter NEC

3.9

19.9

206

213

Kela drug reimbursment

Fat metabolism disorder associated with chronic coronary artery disease

1.9

19.8

327

1762

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.5

19.7

1100

8228

Z29

ICPC

Social problem NOS

6.5

19.7

NF1BA

NOMESCO Finland

Hip extensive X-ray examination

3.3

19.7

104

313

R11

ICD-10 Finland

Nausea and vomiting

2.5

19.7

168

679

D21

ICPC

Swallowing problem

8.5

19.6

N04BD01

ATC

selegiline; oral

55.1

19.4

F0024, G301

ICD-10 Finland

+∞

19.4

I63.5

ICD-10 Finland

Cerebral infarction due to unspecified occlusion or stenosis of cerebral arteries

+∞

19.4

AAF20

NOMESCO Finland

Revision of shunt of ventricle of brain

+∞

19.4

I61.1

ICD-10 Finland

Intracerebral haemorrhage in hemisphere, cortical

+∞

19.4

M54.5

ICD-10 Finland

Low back pain

1.7

19.4

459

2773

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.6

19.3

719

4902

A10BB12

ATC

glimepiride; oral

2.0

19.2

258

1283

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.8

19.2

361

2031

I67.1

ICD-10 Finland

Cerebral aneurysm, nonruptured

100.6

19.2

R25.1

ICD-10 Finland

Tremor, unspecified

5.9

19.1

G04BD08

ATC

solifenacin; oral

2.4

19.0

170

705

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.8

19.0

127

446

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.4

19.0

175

737

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.7

18.8

474

2915

M48.0

ICD-10 Finland

Spinal stenosis

2.0

18.8

265

1347

R44.3

ICD-10 Finland

Hallucinations, unspecified

30.0

18.8

T90

ICPC

Diabetes non-insulin dependent

1.7

18.8

490

3045

N04AA02

ATC

biperiden; systemic

24.9

18.6

N06AX12

ATC

bupropion; oral

21.6

18.5

S06.2

ICD-10 Finland

Diffuse brain injury

+∞

18.4

30041

ICD-8 Finland

Neuroses, Depressiva

+∞

18.4

3540A

ICD-9 Finland

Mononeuritis of upper limb and mononeuritis multiplex, Carpal tunnel syndrome

+∞

18.4

G40.12

ICD-10 Finland

Simple partial seizures with secondary generalization

+∞

18.4

3039X

ICD-9 Finland

Alcohol dependence syndrome, Other and unspecified alcohol dependence

+∞

18.4

F01.19

ICD-10 Finland

Multi-infarct dementia without information on additional symptoms

+∞

18.4

G04CB01

ATC

finasteride; oral (testosterone-5-alpha reductase inhibitors)

1.7

18.4

451

2749

UKC02

NOMESCO Finland

Cystoscopy

1.7

18.3

480

2982

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

2.4

18.2

154

622

N05AX12

ATC

aripiprazole; systemic

181.9

18.2

N03AX16

ATC

pregabalin; oral

1.8

18.0

342

1927

S97

ICPC

Chronic ulcer skin

2.5

18.0

150

601

N05AA02

ATC

levomepromazine; systemic

4.4

17.9

142

N03AB02

ATC

phenytoin; systemic

14.4

17.9

N39.4

ICD-10 Finland

Other specified urinary incontinence

2.4

17.9

163

684

W06

ICD-10 Finland

Fall involving bed

10.9

17.9

SPAT1276

SPAT

Outlining of treatment with patient or their family members

4.0

17.7

171

S32.0

ICD-10 Finland

Fracture of lumbar vertebra

3.4

17.7

259

C01DA14

ATC

isosorbide mononitrate; oral

1.6

17.7

638

4301

PA7BD

NOMESCO Finland

CT angiography of neck and brain

11.3

17.7

103

Kela drug reimbursment

Diabetes, insulin-treated

1.6

17.7

644

4349

F20.9

ICD-10 Finland

Schizophrenia, unspecified

+∞

17.4

G04BD07

ATC

tolterodine; oral

2.4

17.4

146

588

F34.1

ICD-10 Finland

Dysthymia

63.8

17.3

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

2.8

17.3

111

382

N19

ICPC

Speech disorder

35.1

17.2

SPAT1284

SPAT

Extensive health certificate

4.2

17.0

154

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

2.9

17.0

107

361

S22.3

ICD-10 Finland

Fracture of rib

2.6

17.0

130

495

SPAT1221

SPAT

Guidance concerning rehabilitation services and livelihood

9.4

17.0

K59.0

ICD-10 Finland

Constipation

2.4

16.8

143

579

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.5

16.8

806

5779

P03

ICPC

Feeling depressed

4.5

16.7

130

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.7

16.6

410

2496

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

30.1

16.6

F01.29

ICD-10 Finland

Subcortical vascular dementia without information on additional symptoms

47.9

16.6

J01DA01

ATC

[U] cefalexin; systemic

1.4

16.6

1220

9525

K59.09

ICD-10 Finland

Constipation, unspecified

2.4

16.4

145

598

N04BA03

ATC

levodopa, decarboxylase inhibitor and COMT inhibitor; oral

+∞

16.4

G31.0

ICD-10 Finland

Circumscribed brain atrophy

+∞

16.4

AAL10

NOMESCO Finland

Intracranial endovascular thrombolysis

+∞

16.4

G21.9

ICD-10 Finland

Secondary parkinsonism, unspecified

+∞

16.4

F00.21

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type of other additional symptoms, mainly paranoidism

+∞

16.4

N05CD07

ATC

temazepam; oral

1.7

16.3

336

1940

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

2.8

16.3

109

385

N06AB03

ATC

fluoxetine; oral

2.5

16.3

129

501

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

5.7

16.3

F01.10

ICD-10 Finland

Multi-infarct dementia without additional symptoms

162.6

16.2

I64

ICD-10 Finland

Stroke, not specified as haemorrhage or infarction

162.6

16.2

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.5

16.1

767

5476

G04BD12

ATC

mirabegron; oral

1.9

16.1

232

1186

R99

ICD-10 Finland

Other ill-defined and unspecified causes of mortality

3.3

15.9

239

M01AC06

ATC

meloxicam; systemic, rectal

1.5

15.8

582

3925

R07.4

ICD-10 Finland

Chest pain, unspecified

1.6

15.8

502

3266

P01

ICPC

Feeling anxious/nervous/tense

4.3

15.7

130

S72.1

ICD-10 Finland

Pertrochanteric fracture

3.0

15.6

289

N05AF03

ATC

chlorprothixene; systemic

16.0

15.6

SPAT1224

SPAT

Implementation of speech therapy rehabilitation plan

9.3

15.6

A10BH05

ATC

linagliptin; oral

2.3

15.4

149

642

G04CA01

ATC

alfuzosin; oral

1.7

15.4

329

1918

F10.20

ICD-10 Finland

Alcohol dependence currently independent

57.4

15.4

R47.0

ICD-10 Finland

Dysphasia and aphasia

31.9

15.3

S06.6

ICD-10 Finland

Traumatic subarachnoid haemorrhage

+∞

15.3

G91.9

ICD-10 Finland

Hydrocephalus, unspecified

+∞

15.3

F10.40

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without seizures

+∞

15.3

G40

ICD-10 Finland

Epilepsy

+∞

15.3

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.5

15.2

536

3572

KMAK

NOMESCO Finland

1.5

15.2

653

4553

PA7AD

NOMESCO Finland

CT angiography of head and neck vasculature

8.3

15.1

SPAT1100

SPAT

Long-term monitoring of blood pressure

2.0

15.0

198

977

NFJ54

NOMESCO Finland

Internal fixation of fracture of upper femur with intramedullary nail

3.8

15.0

164

G04CB02

ATC

dutasteride; oral

1.9

15.0

231

1210

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.5

14.9

729

5220

N03AE01

ATC

clonazepam; systemic

3.5

14.8

190

Z60.8

ICD-10 Finland

Other problems related to social environment

43.0

14.7

G45.3

ICD-10 Finland

Amaurosis fugax

43.0

14.7

PA7CD

NOMESCO Finland

CT angiography of neck and brain, extensive

17.0

14.7

A10AD05

ATC

insulin aspart; parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)

3.3

14.7

222

A10AC01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)

2.0

14.6

185

900

D07AC01

ATC

betamethasone; topical

1.5

14.5

620

4310

F10.09

ICD-10 Finland

Alcohol intoxication UNS

54.2

14.4

P76

ICPC

Depressive disorder

6.8

14.4

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.5

14.4

509

3391

N06AX03

ATC

mianserin; oral

3.4

14.4

195

P15

ICPC

Chronic alcohol abuse

15.7

14.3

F00.23

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type of other additional symptoms, mainly depression

+∞

14.3

3004A

ICD-9 Finland

Neurotic disorders, Neurotic depression

+∞

14.3

G81.9

ICD-10 Finland

Hemiplegia, unspecified

+∞

14.3

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

+∞

14.3

F00.19

ICD-10 Finland

Dementia in Alzheimer's disease with late onset without information about additional symptoms

76.6

14.3

SPAT1138

SPAT

Guidance concerning bowel function

4.7

14.2

SPAT1157

SPAT

Guidance concerning treatment of mouth and mucous membranes

5.1

14.1

SPAT1325

SPAT

Vaccination

1.4

13.9

824

6106

C07AB02

ATC

metoprolol; systemic

1.5

13.9

635

4473

N06AB05

ATC

paroxetine; oral

4.1

13.9

128

I63.8

ICD-10 Finland

Other cerebral infarction

40.6

13.8

N03AX12

ATC

gabapentin; oral

1.9

13.7

196

1000

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

0.1

13.7

503

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.7

13.7

333

2016

SPAT1097

SPAT

Recording of ECG

1.7

13.6

334

2025

G51.0

ICD-10 Finland

Bell palsy

11.4

13.6

-1

ICPC

4.1

13.6

126

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

10.4

13.5

F10.25

ICD-10 Finland

Alcohol dependence continuous use

51.0

13.5

R44.1

ICD-10 Finland

Visual hallucinations

12.1

13.4

SAD02

NOMESCO Finland

Assessment of need for oral health care, extensive

4.0

13.3

128

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

2.4

13.3

119

493

F00.22

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type other additional symptoms, mainly hallucinations

+∞

13.3

30300

ICD-8 Finland

Alcoholism, Episodic excessive drinking

+∞

13.3

G41.9

ICD-10 Finland

Status epilepticus, unspecified

+∞

13.3

F33.30

ICD-10 Finland

Recurrent depression, severe episode without somatic syndrome

+∞

13.3

30320

ICD-8 Finland

Alcoholism, Alcoholic addiction

+∞

13.3

F009, G308

ICD-10 Finland

+∞

13.3

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

71.8

13.3

F99

ICD-10 Finland

Mental disorder, not otherwise specified

71.8

13.3

G31.9

ICD-10 Finland

Degenerative disease of nervous system, unspecified

133.7

13.2

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

5.7

13.1

A02BC03

ATC

lansoprazole; oral

1.5

13.1

581

4058

D07AA02

ATC

hydrocortisone; topical

1.8

13.1

217

1166

L76

ICPC

Fracture: other

3.1

13.1

221

G56.2

ICD-10 Finland

Lesion of ulnar nerve

15.5

13.0

F01.30

ICD-10 Finland

Mixed cortical and subcortical vascular dementia without additional symptoms

24.6

13.0

2402

FHL

External neurolysis of the nerve and possible alteration of the pathway (nerve pressure)

8.4

13.0

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

8.9

13.0

H53.4

ICD-10 Finland

Visual field defects

5.4

12.8

Y94.0

ICD-10 Finland

Accident at home

4.3

12.8

106

N06AA09

ATC

amitriptyline; systemic

2.1

12.7

140

644

Z60.9

ICD-10 Finland

Problem related to social environment, unspecified

27.1

12.6

I20.99

ICD-10 Finland

Angina pectoris, unspecified

1.8

12.6

208

1115

T90.5

ICD-10 Finland

Sequelae of intracranial injury

47.8

12.5

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.5

12.5

509

3487

A46

ICD-10 Finland

Erysipelas

1.6

12.3

306

1858

I63

ICD-10 Finland

Cerebral infarction

66.7

12.3

AA7AA

NOMESCO Finland

Liquor cerebri shunt X-ray examinatin without contrast

+∞

12.3

AAA20

NOMESCO Finland

Insertion of intraventricular pressure monitoring device

+∞

12.3

G91.1

ICD-10 Finland

Obstructive hydrocephalus

+∞

12.3

2968A

ICD-9 Finland

Affective psychoses, Manic-depressive psychosis, other and unspecified

+∞

12.3

F10.73

ICD-10 Finland

Residual or late-onset psychosis caused by alcohol dementia

+∞

12.3

F06.0

ICD-10 Finland

Organic hallucinosis

+∞

12.3

Z01.9

ICD-10 Finland

Special examination, unspecified

2.5

12.2

368

PA2BD

NOMESCO Finland

Extensive CT angiography of brain

14.7

12.2

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.2

12.2

130

588

N05BA01

ATC

diazepam; systemic, rectal

1.8

12.2

227

1265

G72.9

ICD-10 Finland

Myopathy, unspecified

124.1

12.2

8070/3-C34.9

ICD-O-3

Squamous cell carcinoma, NOS, of lung, NOS

0.1

12.1

422

SPAT1310

SPAT

Counselling related to known health issue

1.5

12.1

551

3861

Z51.88

ICD-10 Finland

Other specified medical care

3.3

11.9

172

SPAT1293

SPAT

Other function in accordance with rehabilitation guidance nomenclature

11.1

11.9

M54.9

ICD-10 Finland

Dorsalgia, unspecified

2.0

11.9

152

744

D07BA04

ATC

hydrocortisone and antiseptics; topical

1.9

11.9

170

868

AXX01

SPAT

4.3

11.9

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

2.0

11.8

153

751

N17

ICPC

Vertigo/dizziness

1.8

11.7

218

1214

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

2.5

11.7

377

A04AA02

ATC

granisetron; systemic, transdermal

0.2

11.7

642

A02BC05

ATC

esomeprazole; systemic

1.4

11.7

654

4759

SPAT1125

SPAT

Stoma care and guidance

3.3

11.7

175

C34.1

ICD-10 Finland

Malignant neoplasm: Upper lobe, bronchus or lung

0.2

11.7

552

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

0.3

11.6

783

G46.8*I67.9

ICD-10 Finland

Other vascular syndromes of brain in cerebrovascular diseases

44.6

11.6

R35

ICD-10 Finland

Polyuria

2.1

11.6

132

614

SPAT1081

SPAT

Cardiorespiratory global assessment

2.0

11.4

149

735

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

5.7

11.4

I95.9

ICD-10 Finland

Hypotension, unspecified

4.1

11.4

100

NB6AA

NOMESCO Finland

Humerus X-ray examination

3.6

11.4

133

M02AA07

ATC

piroxicam; topical

1.4

11.4

728

5426

N39.9

ICD-10 Finland

Disorder of urinary system, unspecified

4.0

11.3

105

R32

ICD-10 Finland

Unspecified urinary incontinence

3.2

11.3

179

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

15.7

11.3

SPAT1014

SPAT

Treatment of eyes

3.5

11.3

144

N05AN01

ATC

lithium; oral

21.8

11.3

35701

ICD-8 Finland

Other diseases of peripheral nerves except autonomic, Nervi mediani

+∞

11.2

F009, F03

ICD-10 Finland

+∞

11.2

F10.49

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without information about seizures

+∞

11.2

S06.9

ICD-10 Finland

Intracranial injury, unspecified

+∞

11.2

30000

ICD-8 Finland

Neuroses, Anxiety neurosis

+∞

11.2

188

Kela drug reimbursment

Psychosis requiring demanding treatment

+∞

11.2

30040

ICD-8 Finland

Neuroses, Neurotico-depressiva

+∞

11.2

G40.19

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures

+∞

11.2

I63.2

ICD-10 Finland

Cerebral infarction due to unspecified occlusion or stenosis of precerebral arteries

+∞

11.2

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

1.6

11.2

301

1863

SCA01

NOMESCO Finland

Simple analysis and advice of nutrition with regard to dentistry

1.6

11.2

283

1726

A05

ICPC

Feeling ill

2.8

11.2

239

IGY02

NOMESCO Finland

Psychiatric monitoring contact

114.6

11.2

G31.2

ICD-10 Finland

Degeneration of nervous system due to alcohol

114.6

11.2

AAF15

NOMESCO Finland

Ventriculoatrial shunt

114.6

11.2

G46.4*I67.9

ICD-10 Finland

Cerebellar stroke syndrome

114.6

11.2

A10BH01

ATC

sitagliptin; oral

1.8

11.2

198

1089

A99

ICPC

Disease/condition unspecnature/site

2.0

11.1

152

763

F01

ICD-10 Finland

Vascular dementia

13.0

11.1

R54

ICD-10 Finland

Senility

8.8

11.1

R06AE07

ATC

cetirizine; oral

1.4

11.1

589

4241

G04BD11

ATC

fesoterodine; oral

2.7

11.0

265

Z51.5

ICD-10 Finland

Palliative care

1.8

11.0

191

1043

L99

ICPC

Musculoskeletal disease other

4.0

10.9

104

EBA00

NOMESCO Finland

Extraction of tooth

1.5

10.9

464

3199

N05AC02

ATC

thioridazine; oral

10.1

10.9

M02AA10

ATC

ketoprofen; topical

1.6

10.8

274

1673

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

1.8

10.8

194

1073

G47.9

ICD-10 Finland

Sleep disorder, unspecified

7.7

10.6

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

2.4

10.6

384

R13

ICD-10 Finland

Dysphagia

2.2

10.6

111

500

F32.0

ICD-10 Finland

Mild depressive episode

7.0

10.5

E87.0

ICD-10 Finland

Hyperosmolality and hypernatraemia

14.8

10.5

N06AX05

ATC

trazodone; oral

6.3

10.5

I67.2

ICD-10 Finland

Cerebral atherosclerosis

26.7

10.4

N04BC04

ATC

ropinirole; oral

26.7

10.4

N05AL01

ATC

sulpiride; systemic

7.4

10.4

AA1ED

NOMESCO Finland

Trauma CT of head and neck

10.1

10.4

Y94.1

ICD-10 Finland

Accident in connection with service housing

57.3

10.4

Angiography of the heart and coronary arteries

1.7

10.4

243

1451

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.5

10.3

385

2577

SPAT1111

SPAT

Planning of analgesia

4.5

10.3

G04CA52

ATC

tamsulosin and dutasteride; systemic

1.6

10.3

261

1595

SPAT1255

SPAT

Intravenous administration of medicine

2.0

10.3

133

653

N06CA01

ATC

amitriptyline and psycholeptics; systemic

2.0

10.3

129

627

F0011, G301

ICD-10 Finland

+∞

10.2

I61.8

ICD-10 Finland

Other intracerebral haemorrhage

+∞

10.2

ICB03

NOMESCO Finland

Psychiatric treatment plan, monitoring

+∞

10.2

30188

ICD-8 Finland

Personality disorders, Alia definita

+∞

10.2

2961D

ICD-9 Finland

Affective psychoses, Manic disorder, recurrent episode[VAKAVA MASENNUSTILA,VAIKEA-ASTEINEN]

+∞

10.2

34609

ICD-8 Finland

Migraine, Unspecified

+∞

10.2

I67.8

ICD-10 Finland

Other specified cerebrovascular diseases

+∞

10.2

AAC00

NOMESCO Finland

Ligature of intracranial aneurysm

+∞

10.2

4300A

ICD-9 Finland

Subarachnoid haemorrhage[HAEMORRHAGIA SUBARACHNOID. POST ANEURYSMA SACCULARE]

+∞

10.2

LAITO

NOMESCO Finland

105.0

10.2

AAF00

NOMESCO Finland

Ventriculostomy

105.0

10.2

ICD-10 Finland

3.2

10.2

162

EBA15

NOMESCO Finland

Extraction of large number of teeth

2.6

10.1

274

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.8

10.1

167

897

S00.0

ICD-10 Finland

Superficial injury of scalp

3.7

10.0

108

C10AA03

ATC

pravastatin; oral

1.8

10.0

175

960

M79.6

ICD-10 Finland

Pain in limb

1.4

10.0

511

3647

SPAT1312

SPAT

General health counselling

1.4

9.9

533

3833

Z11

ICPC

Compliance/being ill problem

9.1

9.9

SPAT1104

SPAT

Monitoring of emergency patient

2.0

9.9

132

656

A03FA01

ATC

metoclopramide; systemic, rectal

0.6

9.8

217

3081

S30.0

ICD-10 Finland

Contusion of lower back and pelvis

3.0

9.8

181

N05BE01

ATC

buspirone; oral

5.5

9.8

H01BA02

ATC

desmopressin; nasal, systemic, sublingual

4.4

9.8

F10.24

ICD-10 Finland

Alcohol depence active use

38.1

9.7

F32.8

ICD-10 Finland

Other depressive episodes

38.1

9.7

F01.3

ICD-10 Finland

Mixed cortical and subcortical vascular dementia

38.1

9.7

R00.1

ICD-10 Finland

Bradycardia, unspecified

2.2

9.7

100

447

S80.0

ICD-10 Finland

Contusion of knee

2.5

9.6

275

R81

ICPC

Pneumonia

2.5

9.6

300

R63.4

ICD-10 Finland

Abnormal weight loss

2.4

9.6

311

P99

ICPC

Psychological disorders other

15.9

9.6

R4120

NOMESCO Finland

Occupational therapy

2.8

9.6

213

A10BB01

ATC

glibenclamide; oral

1.8

9.5

176

980

N03AX09

ATC

lamotrigine; oral

11.6

9.5

S28

ICPC

Limited function/disability (S)

7.3

9.5

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

0.2

9.5

450

XF606

NOMESCO Finland

Ortostatic test

7.7

9.4

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

52.5

9.4

P04

ICPC

Feeling/behaving irritable/angry

52.5

9.4

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

52.5

9.4

F33.4

ICD-10 Finland

Recurrent depressive disorder, currently in remission

52.5

9.4

K89

ICPC

Transient cerebral ischaemia

9.1

9.4

SAA03

NOMESCO Finland

Extended examination of mouth

1.4

9.4

433

3021

D01AC02

ATC

miconazole; topical

1.8

9.3

174

972

K08.3

ICD-10 Finland

Retained dental root

2.0

9.2

117

572

F02.89

ICD-10 Finland

Dementia in another specified disease that is classified elsewhere without information of additional symptoms

+∞

9.2

N03AX18

ATC

lacosamide; systemic

+∞

9.2

WX780

NOMESCO Finland

Remote monitoring CPAP

+∞

9.2

F00.1

ICD-10 Finland

Dementia in Alzheimer disease with late onset

+∞

9.2

G40.6

ICD-10 Finland

Grand mal seizures, unspecified (with or without petit mal)

+∞

9.2

43399

ICD-8 Finland

Cerebral thrombosis, Without mention of hypertension

+∞

9.2

F01.0

ICD-10 Finland

Vascular dementia of acute onset

+∞

9.2

F20.00

ICD-10 Finland

Paranoid schizophrenia continuous

+∞

9.2

T85.0

ICD-10 Finland

Mechanical complication of ventricular intracranial (communicating) shunt

+∞

9.2

43599

ICD-8 Finland

Transient cerebral ischaemia, Without mention of hypertension

+∞

9.2

Z28

ICPC

Limited function/disability (Z)

8.0

9.2

T89

ICPC

Diabetes insulin dependent

3.4

9.2

122

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

1.7

9.2

193

1117

Z25.8

ICD-10 Finland

Need for immunization against other specified single viral diseases

0.4

9.2

933

315

Kela drug reimbursment

Clopidogrel

4.5

9.1

SAA01

NOMESCO Finland

Simple examination of mouth

1.3

9.1

866

6821

N03AX11

ATC

topiramate; oral

20.7

9.1

I21.49

ICD-10 Finland

Acute subendocardial infarction unspecified coronary artery status

1.7

9.1

182

1039

-2

ICPC

5.2

9.1

ABC36

NOMESCO Finland

Decompression of lumbar nerve roots

2.2

9.0

406

D07BC01

ATC

betamethasone and antiseptics; topical

1.6

9.0

211

1263

R4180

NOMESCO Finland

Podiatric therapy

7.7

9.0

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

4.6

9.0

M80.0

ICD-10 Finland

Postmenopausal osteoporosis with pathological fracture

3.0

9.0

164

R31

ICD-10 Finland

Unspecified haematuria

1.5

8.9

278

1783

N07BB01

ATC

disulfiram; oral

4.9

8.9

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

3.4

8.9

120

D07AB02

ATC

hydrocortisone butyrate; topical

1.4

8.9

461

3286

F41.1

ICD-10 Finland

Generalized anxiety disorder

13.0

8.9

K02.1

ICD-10 Finland

Caries of dentine

1.4

8.9

640

4828

N06AA12

ATC

doxepin; systemic

2.3

8.9

339

SPAT1352

SPAT

Inspection, maintenance and instruction for use of hearing aid

2.7

8.9

201

XKD00

NOMESCO Finland

Uroflowmetry

1.4

8.8

445

3154

G25.0

ICD-10 Finland

Essential tremor

4.2

8.8

N30

ICD-10 Finland

Cystitis

2.0

8.8

108

523

A23

ICPC

Risk factor NOS

2.4

8.8

277

I69

ICD-10 Finland

Sequelae of cerebrovascular disease

35.0

8.8

8000/3-C34.9

ICD-O-3

Neoplasm, malignant of lung, NOS

0.2

8.8

450

S20.2

ICD-10 Finland

Contusion of thorax

2.4

8.8

296

M01AE03

ATC

ketoprofen; systemic, rectal

1.3

8.7

712

5471

S42.2

ICD-10 Finland

Fracture of upper end of humerus

2.1

8.7

423

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

2.1

8.7

100

471

S01.1

ICD-10 Finland

Open wound of eyelid and periocular area

3.2

8.7

133

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

2.0

8.7

104

497

L75

ICPC

Fracture: femur

3.3

8.6

123

AA1AA

NOMESCO Finland

Head X-ray examination

5.6

8.6

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

2.0

8.6

102

486

C34.3

ICD-10 Finland

Malignant neoplasm: Lower lobe, bronchus or lung

0.2

8.6

367

S22.4

ICD-10 Finland

Multiple fractures of ribs

3.1

8.5

140

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

1.4

8.5

476

3439

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.8

8.5

155

862

K78

ICPC

Atrial fibrillation/flutter

1.6

8.5

223

1375

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

2.4

8.5

278

N04BC05

ATC

pramipexole; oral

2.0

8.5

105

509

8140/3-C34.9

ICD-O-3

Adenocarcinoma, NOS, of lung, NOS

0.0

8.5

232

F00.29

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type without information on additional symptoms

47.7

8.5

4912B

ICD-9 Finland

Chronic bronchitis, Obstructive chronic bronchitis[BRONCHITIS OBSTRUCTIVA CUM EMPHYSEMATE]

0.2

8.4

344

G04BD10

ATC

darifenacin; oral

5.6

8.4

E78.00

ICD-10 Finland

Familial hypercholesterolaemia

2.1

8.4

432

E11.6

ICD-10 Finland

Type 2 diabetes mellitus, with other specified complications

3.0

8.3

148

L01BC06

ATC

capecitabine; oral

0.3

8.3

484

SPAT1285

SPAT

Provision of consultation response

2.0

8.3

472

NE1AD

NOMESCO Finland

Pelvis and hip bones CT examination

3.0

8.2

152

G99.2*M47.1

ICD-10 Finland

Spondylogenic compression of spinal cord

85.9

8.2

G93.0

ICD-10 Finland

Cerebral cysts

85.9

8.2

F02.09*G31.0

ICD-10 Finland

Dementia in Pick's disease without information on additional symptoms

85.9

8.2

AA400

NOMESCO Finland

Electroconvulsive therapy

85.9

8.2

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

8.6

8.2

R41

ICD-10 Finland

Other symptoms and signs involving cognitive functions and awareness

5.5

8.2

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.5

8.2

278

1819

K92.1

ICD-10 Finland

Melaena

1.8

8.2

138

749

3050A

ICD-9 Finland

Nondependent abuse of drugs, Alcohol abuse

+∞

8.2

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

+∞

8.2

35708

ICD-8 Finland

Other diseases of peripheral nerves except autonomic, Alterius nervi

+∞

8.2

N88

ICPC

Epilepsy

+∞

8.2

WX723

NOMESCO Finland

CPAP therapy

+∞

8.2

30088

ICD-8 Finland

Neuroses, Other

+∞

8.2

ICC04

NOMESCO Finland

Psychiatric treatment plan, permanent discontinuation

+∞

8.2

F01.34

ICD-10 Finland

Mixed cortical and subcortical vascular dementia are other mixed symptoms of mixed type

+∞

8.2

3074A

ICD-9 Finland

Special symptoms or syndromes not elsewhere classified, Specific disorders of sleep of nonorganic origin[UNIHÄIRIÖ]

+∞

8.2

NFQ20

NOMESCO Finland

Amputation of femur

3.9

8.2

G04BD04

ATC

oxybutynin; oral, transdermal

1.8

8.1

128

679

E11.3

ICD-10 Finland

Type 2 diabetes mellitus, with ophthalmic complications

2.5

8.1

231

R07.3

ICD-10 Finland

Other chest pain

1.8

8.1

142

780

C09CA01

ATC

losartan; oral

1.4

8.1

478

3486

SPAT1281

SPAT

Other administrative function

1.8

8.0

133

718

M80.9

ICD-10 Finland

Unspecified osteoporosis with pathological fracture

2.8

8.0

178

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.7

8.0

149

835

SPAT1243

SPAT

Psychiatric/psychological examination

10.2

8.0

S01.9

ICD-10 Finland

Open wound of head, part unspecified

3.9

8.0

AA1CM

NOMESCO Finland

Extensive MRI examination of brain with 3 Tesla magnet

6.7

7.9

F80.1

ICD-10 Finland

Expressive language disorder

31.8

7.9

R40.0

ICD-10 Finland

Somnolence

31.8

7.9

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

2.7

7.9

188

M03BX02

ATC

tizanidine; oral

1.3

7.9

685

5304

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

1.3

7.8

670

5171

M03BX01

ATC

baclofen; systemic

7.2

7.8

D12

ICPC

Constipation

2.3

7.8

308

G56.3

ICD-10 Finland

Lesion of radial nerve

21.0

7.8

P72

ICPC

Schizophrenia

21.0

7.8

ZXA00

NOMESCO Finland

Right side

1.3

7.8

554

4158

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

3.2

7.8

118

Z03

ICPC

Housing/neighbourhood problem

9.6

7.7

R29.6

ICD-10 Finland

Tendency to fall, not elsewhere classified

8.5

7.7

U05

ICPC

Urination problems other

2.0

7.7

475

ABC60

NOMESCO Finland

Decompression of cervical spinal cord

12.4

7.6

F01.2

ICD-10 Finland

Subcortical vascular dementia

12.4

7.6

C34.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of bronchus and lung

0.1

7.6

239

S22.0

ICD-10 Finland

Fracture of thoracic vertebra

3.0

7.6

131

N05BA02

ATC

chlordiazepoxide; systemic

3.7

7.6

IGY99

NOMESCO Finland

Other psychiatric treatment contact

42.9

7.5

C03AA03

ATC

hydrochlorothiazide; oral

1.5

7.5

233

1492

SPAT1127

SPAT

Enema

3.9

7.5

F41.09

ICD-10 Finland

UNS Panic Syndrome

9.0

7.5

S52.5

ICD-10 Finland

Fracture of lower end of radius

1.7

7.5

162

948

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.4

7.5

388

2764

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

2.6

7.5

193

K99

ICPC

Cardiovascular disease other

2.2

7.5

323

WX212

NOMESCO Finland

Femoral plexus blockade

2.6

7.5

200

C34.31

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung epidermoid carcinoma

0.0

7.4

177

P19

ICPC

Drug abuse

17.5

7.4

G45.8

ICD-10 Finland

Other transient cerebral ischaemic attacks and related syndromes

23.8

7.4

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

23.8

7.4

A10BX01

ATC

guar gum; systemic

1.9

7.4

112

586

W00

ICD-10 Finland

Fall on same level involving ice and snow

1.7

7.4

148

850

J01MA06

ATC

norfloxacin; oral

1.5

7.3

238

1544

T83.0

ICD-10 Finland

Mechanical complication of urinary (indwelling) catheter

8.4

7.3

A02BC01

ATC

omeprazole; systemic

1.3

7.3

560

4252

G82.2

ICD-10 Finland

Paraplegia, unspecified

76.3

7.3

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

76.3

7.3

N04BD02

ATC

rasagiline; oral

76.3

7.3

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

2.1

7.3

358

A10AB04

ATC

insulin lispro; parenteral (insulins and analog. for injection, fast-acting)

3.1

7.2

114

111

Conventional CABG

3.1

7.2

114

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

2.3

7.2

253

C07AA05

ATC

propranolol; systemic

1.6

7.2

188

1159

N31.2

ICD-10 Finland

Flaccid neuropathic bladder, not elsewhere classified

5.2

7.2

P28

ICPC

Limited function/disability (P)

12.7

7.2

AA1BM

NOMESCO Finland

MRI examination of brain with 3 Tesla magnet

12.7

7.2

F06.2

ICD-10 Finland

Organic delusional [schizophrenia-like] disorder

+∞

7.2

F0289, G318

ICD-10 Finland

+∞

7.2

IGP01

NOMESCO Finland

Psychiatric family contact

+∞

7.2

AAF25

NOMESCO Finland

Removal of shunt of ventricle of brain

+∞

7.2

IAB14

NOMESCO Finland

Geriatric psychiatry consultation

+∞

7.2

34599

ICD-8 Finland

Epilepsy, Other and unspecified

+∞

7.2

119

Kela drug reimbursment

Trigeminal neuralgia or glossofaryngeusneuralgia

+∞

7.2

F00.09

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, presenile onset information on additional symptoms is lacking

+∞

7.2

I60.1

ICD-10 Finland

Subarachnoid haemorrhage from middle cerebral artery

+∞

7.2

G21.1

ICD-10 Finland

Other drug-induced secondary parkinsonism

+∞

7.2

N04BC09

ATC

rotigotine; transdermal

+∞

7.2

G41.0

ICD-10 Finland

Grand mal status epilepticus

+∞

7.2

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

+∞

7.2

AAD05

NOMESCO Finland

Evacuation of acute subdural haematoma

+∞

7.2

183

Kela drug reimbursment

Lamotrigin and topiramate

+∞

7.2

4309X

ICD-9 Finland

Subarachnoid haemorrhage[HAEMORRHAGIA SUBARACHNOIDALIS NUD]

+∞

7.2

F0010, G308

ICD-10 Finland

+∞

7.2

PA3AC

NOMESCO Finland

Carotis angiography with X-ray

+∞

7.2

2161

FHL

Neck ligation, big brain

+∞

7.2

G40.10

ICD-10 Finland

Simple partial seizures

+∞

7.2

G46.3*I67.9

ICD-10 Finland

Brain stem stroke syndrome (I60-I67+)

+∞

7.2

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.6

7.1

184

1130

SAA02

NOMESCO Finland

Basic examination of mouth

1.3

7.1

732

5783

A08.4

ICD-10 Finland

Viral intestinal infection, unspecified

3.1

7.1

111

G45

ICD-10 Finland

Transient cerebral ischaemic attacks and related syndromes

10.3

7.1

N31.1

ICD-10 Finland

Reflex neuropathic bladder, not elsewhere classified

8.0

7.0

M01AH03

ATC

valdecoxib; oral

2.0

7.0

432

E979A

ICD-9 Finland

DAMAGE OCCURRED BY ANOTHER OR SPECIFIED WAY

8.9

7.0

P27

ICPC

Fear of mental disorder

15.0

7.0

N05BA12

ATC

alprazolam; oral

1.8

7.0

113

605

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

1.7

7.0

136

774

E000002

ATC

1.7

7.0

151

886

F06.9

ICD-10 Finland

Unspecified mental disorder due to brain damage and dysfunction and to physical disease

28.6

7.0

I20.89

ICD-10 Finland

Other angina pectoris unspecified coronary artery status

1.8

6.9

123

680

359

Kela drug reimbursment

Mirabegroni

5.5

6.9

4289X

ICD-9 Finland

Heart failure, unspecified

0.0

6.9

163

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.4

6.9

350

2480

K77

ICPC

Heart failure

2.2

6.9

278

AN1

Coronary angiography

1.4

6.9

308

2133

F17.29

ICD-10 Finland

Addiction caused by tobacco UNS

11.5

6.9

R01AD09

ATC

mometasone; nasal

1.3

6.8

491

3684

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

1.6

6.8

187

1167

E87.6

ICD-10 Finland

Hypokalaemia

2.4

6.8

233

M01AE01

ATC

ibuprofen; systemic, rectal

1.3

6.8

1439

12391

D07CA01

ATC

hydrocortisone and antibiotics; topical

1.5

6.8

203

1292

A02BA02

ATC

ranitidine; systemic

1.4

6.8

429

3157

SPAT1313

SPAT

Guidance and counselling related to accident prevention

5.7

6.8

R40.2

ICD-10 Finland

Coma, unspecified

4.8

6.8

S01

ICD-10 Finland

Open wound of head

3.7

6.7

Z08

ICPC

Social welfare problem

6.6

6.7

XA402

NOMESCO Finland

ENMG

4.3

6.7

WD115

NOMESCO Finland

Multiple cystostatic therapy of methastized malignancy

0.1

6.7

256

280

Kela drug reimbursment

Clopidogrel

2.5

6.7

183

WX402

NOMESCO Finland

General anaesthesia

0.6

6.7

1259

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

1.9

6.7

433

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

1.8

6.6

110

596

E000006

ATC

1.8

6.6

108

581

I20.81

ICD-10 Finland

Other angina pectoris stenosed coronary artery

1.5

6.6

256

1724

S01.3

ICD-10 Finland

Open wound of ear

3.9

6.6

F09

ICD-10 Finland

Unspecified organic or symptomatic mental disorder

38.1

6.6

G62.1

ICD-10 Finland

Alcoholic polyneuropathy

38.1

6.6

A03FA02

ATC

cisapride; oral, rectal

1.6

6.6

158

951

G63.2*E11.4

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic polyneuropathy

7.9

6.6

S01.8

ICD-10 Finland

Open wound of other parts of head

3.8

6.6

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.5

6.6

246

1646

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

3.5

6.5

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.3

6.5

559

4301

XFP96

NOMESCO Finland

Other intraoperative electrophysiological investigation in arhythmia or disturbance of impulse propagation

2.5

6.5

190

WF049

NOMESCO Finland

Radiotherapy of metastasis

0.3

6.5

457

G55.1*M51.1

ICD-10 Finland

Compression of nerve roots and nerve plexus in disc diseases in the lumbar region and other regions

21.4

6.5

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.4

6.5

291

2015

A01AB09

ATC

miconazole; local oral

1.6

6.5

171

1056

Z43.5

ICD-10 Finland

Attention to cystostomy

5.0

6.4

SPAT1107

SPAT

Extensive external surface anaesthesia of skin with cream or gel

6.8

6.4

J01AA02

ATC

doxycycline; systemic

1.2

6.4

1480

12827

J45.9

ICD-10 Finland

Asthma, unspecified

1.4

6.4

279

1924

C09AA04

ATC

perindopril; oral

1.7

6.4

118

660

N06AX22

ATC

agomelatine; oral

11.7

6.4

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.9

6.4

471

NAG40

NOMESCO Finland

Anterior fusion of cervical spine without fixation

6.1

6.4

J01XE01

ATC

nitrofurantoin; oral

2.8

6.3

131

A41.9

ICD-10 Finland

Sepsis, unspecified

1.9

6.3

462

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

5.6

6.3

M01AX05

ATC

glucosamine; oral

1.3

6.3

418

3093

F00.11

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, senile onset other additional symptoms, mainly paranoidism

66.5

6.3

G31.1

ICD-10 Finland

Senile degeneration of brain, not elsewhere classified

66.5

6.3

N05AF05

ATC

zuclopenthixol; systemic

66.5

6.3

T91.3

ICD-10 Finland

Sequelae of injury of spinal cord

66.5

6.3

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.5

6.3

181

1144

N06AG02

ATC

moclobemide; oral

2.8

6.3

126

D07AC13

ATC

mometasone; topical

1.3

6.2

455

3417

H91.1

ICD-10 Finland

Presbycusis

1.5

6.2

208

1355

C10AA04

ATC

fluvastatin; oral

1.5

6.2

232

1551

L03AA02

ATC

filgrastim; parenteral

0.2

6.2

266

C34.11

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary epidermoid carcinoma

0.2

6.2

245

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

0.3

6.2

466

Z75.0

ICD-10 Finland

Medical services not available in home

13.6

6.2

A04AA01

ATC

ondansetron; systemic, rectal

0.4

6.2

690

N12

ICD-10 Finland

Tubulo-interstitial nephritis, not specified as acute or chronic

2.5

6.2

174

X58

ICD-10 Finland

Exposure to other specified factors

1.7

6.2

133

779

A78

ICPC

Infectious disease other/NOS

4.8

6.2

M01AX17

ATC

nimesulide; oral

1.3

6.2

422

3138

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.3

6.2

519

3981

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

2.8

6.1

122

F25.9

ICD-10 Finland

Schizoaffective disorder, unspecified

+∞

6.1

4351A

ICD-9 Finland

Transient cerebral ischaemia, Vertebral artery syndrome

+∞

6.1

4380A

ICD-9 Finland

Late effects of cerebrovascular disease[SEQUELAE MORBI CEREBROVASCULARIS]

+∞

6.1

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

+∞

6.1

F00.12

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, senile onset, other additional symptoms, mainly hallucinations

+∞

6.1

F0013, G301

ICD-10 Finland

+∞

6.1

F45.0

ICD-10 Finland

Somatization disorder

+∞

6.1

IBA04

NOMESCO Finland

Extensive initial psychiatric evaluation

+∞

6.1

N04BX02

ATC

entacapone; oral

+∞

6.1

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

+∞

6.1

F00, F03

ICD-10 Finland

+∞

6.1

4359X

ICD-9 Finland

Transient cerebral ischaemia, Unspecified transient cerebral ischaemia

+∞

6.1

G40.7

ICD-10 Finland

Petit mal, unspecified, without grand mal seizures

+∞

6.1

I61.6

ICD-10 Finland

Intracerebral haemorrhage, multiple localized

+∞

6.1

F10.31

ICD-10 Finland

Withdrawal symptoms caused by alcohol with seizures

+∞

6.1

N07AA05

ATC

+∞

6.1

G95.8

ICD-10 Finland

Other specified diseases of spinal cord

+∞

6.1

2961E

ICD-9 Finland

Affective psychoses, Manic disorder, recurrent episode[VAKAVA MASENNUSTILA,VAIKEA-ASTEINEN+PSYKOOT PIIRTEI]

+∞

6.1

I62.9

ICD-10 Finland

Intracranial haemorrhage (nontraumatic), unspecified

+∞

6.1

F20.30

ICD-10 Finland

Undifferentiated schizophrenia continuous

+∞

6.1

F0021, G301

ICD-10 Finland

+∞

6.1

G21.8

ICD-10 Finland

Other secondary parkinsonism

+∞

6.1

F07.8

ICD-10 Finland

Other organic personality and behavioural disorders due to brain disease, damage and dysfunction

+∞

6.1

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

+∞

6.1

30310

ICD-8 Finland

Alcoholism, Habitual excessive drinking

+∞

6.1

4341A

ICD-9 Finland

Occlusion of cerebral arteries, Cerebral embolism

+∞

6.1

30399

ICD-8 Finland

Other and unspecified alcoholism

+∞

6.1

K03.66

ICD-10 Finland

Tooth plaque

1.9

6.1

408

XJH00

NOMESCO Finland

Transanal ultrasonography

1.5

6.1

202

1315

R1230

NOMESCO Finland

Neuropsychological evaluation of need and possibilities to rehabilitation

17.2

6.1

R45.1

ICD-10 Finland

Restlessness and agitation

17.2

6.1

Z03.2

ICD-10 Finland

Observation for suspected mental and behavioural disorders

17.2

6.1

N06AX18

ATC

reboxetine; oral

10.5

6.1

T68

ICD-10 Finland

Hypothermia

10.5

6.1

I50.0

ICD-10 Finland

Congestive heart failure

1.4

6.1

252

1720

N06AA04

ATC

clomipramine; systemic

5.7

6.0

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3019309) Folate [Moles/volume] in Red Blood Cells

1372

4314

3.98

307.22

2.2

1.7

1389.65

1140.05

nmol/l

15.10

982

3117

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1152

4527

2.84

159.89

2.4

1.7

261.63

234.66

u/l

0.38

1034

4079

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1104

4395

2.76

147.45

1.9

1.7

417.39

20525348.05

pmol/l

2.36

831

3391

(3026008) Bacteria identified in Urine by Culture

1419

6825

2.39

122.79

4.4

3.3

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1547

7741

2.36

122.13

5.2

3.8

56.66

85.46

ng/l

1.46

1276

6127

(3029937) Albumin [Presence] in Urine by Test strip

1093

4743

2.48

117.79

6.1

4.0

0.00

estimate

0.00

251

1552

(3031040) Bacteria [#/volume] in Urine by Automated count

2147

12658

2.32

111.24

7.3

4.7

3615.75

1648.57

e6/l

1.14

126

217

(3023368) Bacteria identified in Blood by Culture

1280

6165

2.29

106.81

4.0

4.1

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

106

13.30

102.25

1.3

1.2

470.47

171.76

e6/l

0.58

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

106

13.30

102.25

1.3

1.1

35.76

94.15

e6/l

0.33

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

117

11.24

101.93

1.2

1.1

523.99

611.79

mg/l

0.69

103

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1330

6672

2.21

98.69

6.0

4.2

—

(3019150) Specific gravity of Urine by Refractometry

878

3766

2.38

93.70

6.6

4.1

1.02

kg/l

0.31

617

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

104

11.02

89.63

1.2

1.1

4.00

3.67

mmol/l

1.29

(3015377) Calcium [Moles/volume] in Serum or Plasma

1269

6526

2.10

85.34

2.6

3.5

2.34

2.35

mmol/l

1.59

1060

5408

(3024561) Albumin [Mass/volume] in Serum or Plasma

1572

8803

2.03

83.29

4.0

4.3

33.59

33.67

g/l

0.18

1359

7965

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

783

3487

2.23

74.26

2.0

1.7

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

364

1118

3.04

74.16

1.6

1.4

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1728

10291

1.94

73.48

5.1

6.0

1.21

mmol/l

0.90

1286

8520

(3015736) pH of Urine

1268

6866

1.97

70.63

5.4

3.6

—

6.00

—

(40761535) Cells panel - Urine sediment

452

1610

2.65

69.79

4.7

3.3

—

(3035350) Ketones [Presence] in Urine by Test strip

1510

8756

1.90

67.72

5.7

3.8

0.00

estimate

0.00

290

1688

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1559

9135

1.90

67.70

4.7

5.3

1.21

mmol/l

0.07

1347

8070

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

503

1937

2.47

65.87

2.8

2.3

5.26

6.64

ug/l

1.16

364

1633

(3009261) Glucose [Presence] in Urine by Test strip

1522

8904

1.88

65.83

5.7

3.9

0.00

estimate

0.00

286

1663

(3013826) Glucose [Moles/volume] in Serum or Plasma

1797

11098

1.87

65.40

5.0

4.1

7.34

6.94

mmol/l

7.81

1685

10348

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

824

3963

2.06

62.76

3.1

3.2

2.46

2.48

mmol/l

4.20

723

3372

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

578

2422

2.29

62.34

1.9

1.7

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1229

6835

1.88

60.96

2.1

77.11

81.53

nmol/l

5.43

976

5765

(3021601) Nitrite [Presence] in Urine by Test strip

1487

8784

1.84

60.85

6.7

5.3

0.00

estimate

0.00

280

1663

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

571

2439

2.24

58.53

1.9

1.6

—

(3044290) Cell count panel - Cerebral spinal fluid

8.60

56.08

1.2

—

(3037467) Urinalysis macro (dipstick) panel - Urine

1960

12791

1.79

55.64

5.7

4.4

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

2466

17298

1.90

54.85

22.5

16.2

32.06

31.09

mg/l

0.59

2164

14138

(3008152) Bicarbonate [Moles/volume] in Arterial blood

374

1359

2.55

54.84

4.7

5.8

24.46

24.18

mmol/l

0.69

354

1260

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1461

8785

1.78

54.47

2.4

2.0

84.77

90.45

pmol/l

4.64

777

4368

(3018418) pH of Serum or Plasma

1091

6070

1.82

52.20

3.2

3.8

7.40

1.33

246

1129

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

561

2493

2.14

51.58

12.8

7.6

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

207

582

3.21

48.48

1.3

1.2

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1075

6119

1.77

46.50

2.6

1.9

—

(3032080) INR in Blood by Coagulation assay

1430

8909

1.68

43.92

13.5

11.7

1.39

1.45

inr

1.06

410

2397

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

1804

12064

1.64

40.97

3.7

15.63

15.33

pmol/l

4.30

1503

10342

(3043409) Potassium [Moles/volume] in Arterial blood

202

619

2.94

40.79

2.7

3.7

3.89

3.94

mmol/l

0.53

173

567

(3019060) Gas panel - Arterial blood

352

1426

2.27

40.10

3.3

3.9

—

(3020891) Body temperature

235

791

2.69

39.85

3.3

4.1

—

(3021960) Folate [Moles/volume] in Serum or Plasma

919

5230

1.72

38.34

1.7

1.5

19.69

19.75

nmol/l

0.03

804

4343

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

2168

15322

1.64

38.14

4.7

4.5

2.10

2.20

mu/l

1.07

1832

13155

(3018405) Lactate [Moles/volume] in Arterial blood

219

734

2.69

37.41

2.6

3.5

1.46

1.47

mmol/l

0.04

213

715

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

988

5793

1.68

36.57

2.4

2.2

3.31

3.16

mg/l

0.95

786

4850

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

949

5551

1.67

35.20

2.3

59.95

62.44

u/l

0.39

838

5038

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

456

2170

1.95

33.73

5.7

3.3

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

332

1408

2.15

33.61

1.6

1.5

—

(40761511) CBC panel - Blood by Automated count

2394

17600

1.63

33.15

23.0

16.3

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

2511

18689

1.66

33.04

26.8

20.3

4.04

4.03

mmol/l

1.39

2351

17998

(3019550) Sodium [Moles/volume] in Serum or Plasma

2509

18671

1.66

33.02

26.9

20.0

139.48

139.42

mmol/l

0.45

2356

18008

(3014271) Vancomycin [Susceptibility]

106

5.47

32.21

3.6

2.7

—

(3041096) Erythrocytes [Presence] in Urine by Automated

810

4643

1.67

31.96

5.0

3.8

—

(3023410) Appearance of Cerebral spinal fluid

12.52

30.95

1.5

1.0

—

(3007461) Platelets [#/volume] in Blood

2515

18837

1.64

30.88

30.9

24.7

235.83

233.98

e9/l

0.59

2361

17994

(3035941) MCH [Entitic mass]

2515

18840

1.64

30.82

30.8

24.6

30.32

30.43

2.02

2378

18297

(3026361) Erythrocytes [#/volume] in Blood

2515

18841

1.64

30.80

30.9

24.7

4.17

4.31

e12/l

28.01

2353

17902

(3024731) MCV [Entitic volume]

2515

18841

1.64

30.80

30.8

24.6

91.94

92.04

0.41

2378

18298

(3000963) Hemoglobin [Mass/volume] in Blood

2515

18843

1.64

30.76

31.2

24.9

125.67

130.10

g/l

36.87

2382

18304

(3010813) Leukocytes [#/volume] in Blood

2515

18845

1.63

30.72

30.9

24.7

7.54

7.11

e9/l

5.70

2356

17902

(3018677) aPTT in Platelet poor plasma by Coagulation assay

495

2509

1.83

29.92

1.6

1.8

29.76

30.73

2.26

474

2434

(3013707) Erythrocyte sedimentation rate by Westergren method

1831

12854

1.52

29.03

3.8

4.0

17.59

17.17

mm/h

0.39

1556

11429

(3020191) Ethanol [Moles/volume] in Serum or Plasma

11.16

28.04

1.1

1.0

0.80

0.64

promille

0.20

(3016502) Oxygen saturation in Arterial blood

444

2227

1.84

27.62

3.6

5.8

94.78

95.01

0.29

426

2126

(3000850) Epithelial cells [#/volume] in Urine

761

4435

1.63

27.54

3.2

2.6

5.52

5.09

e6/l

0.43

701

3843

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

165

565

2.60

26.97

1.5

1.3

1.58

1.67

0.50

131

442

(3002173) Hemoglobin [Mass/volume] in Arterial blood

406

2011

1.85

26.22

3.8

6.2

118.87

117.28

g/l

0.82

391

1931

(40768804) Tissue Pathology biopsy report

577

7408

0.60

25.57

2.2

2.4

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

1985

14404

1.48

24.89

5.4

7.2

83.64

85.82

u/l

0.57

1745

13320

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1194

7893

1.48

23.79

3.4

3.1

2346.11

2262.05

ng/l

0.19

979

6906

(3003396) Base excess in Arterial blood by calculation

470

2499

1.73

23.78

3.6

5.7

1.41

0.96

mmol/l

1.36

332

1874

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

7.48

23.68

1.3

1.1

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

708

4190

1.59

23.56

6.1

3.5

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

146

511

2.54

22.84

1.8

2.3

557.47

488.65

ug/l

0.22

130

494

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

279

4247

0.53

22.76

1.5

1.6

1.20

1.22

mmol/l

0.32

225

3404

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

1219

8258

1.44

20.57

2.8

57.93

61.40

u/l

0.46

1014

7163

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

362

1867

1.76

20.23

3.5

1.23

1.22

mmol/l

0.90

279

1590

(3012501) Base excess in Blood by calculation

130

458

2.51

20.09

3.8

4.2

2.56

2.80

mmol/l

0.41

286

(3013290) Carbon dioxide [Partial pressure] in Blood

130

459

2.51

20.00

3.8

4.2

4.96

kpa

0.01

123

443

(3027315) Oxygen [Partial pressure] in Blood

130

462

2.49

19.73

3.8

4.2

7.85

8.12

kpa

1.08

123

446

(3027801) Oxygen [Partial pressure] in Arterial blood

450

2497

1.65

19.16

3.7

5.7

10.84

11.74

kpa

3.84

423

2340

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

450

2498

1.64

19.13

3.7

5.7

4.93

5.03

kpa

1.43

424

2341

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1417

9960

1.40

18.94

3.8

5.9

12.34

13.47

umol/l

2.13

1247

9405

(3010421) pH of Blood

139

525

2.35

18.49

3.8

4.0

7.42

0.43

123

442

(4035726)

1914

0.39

18.43

1.2

1.3

—

(3047181) Lactate [Moles/volume] in Blood

156

621

2.23

18.36

4.2

4.7

1.55

1.38

mmol/l

0.72

138

555

(3022217) INR in Platelet poor plasma by Coagulation assay

573

3404

1.55

18.26

34.2

32.6

1.70

1.65

inr

0.19

463

(3016018) Differential panel - Cerebral spinal fluid

6.70

18.00

1.3

1.1

—

(3052592) Norovirus Ag [Presence] in Stool

6.97

17.38

1.5

1.2

—

(3009542) Hematocrit [Volume Fraction] of Blood

1964

14747

1.37

16.62

22.9

19.0

34.62

36.84

5.72

672

8379

(40761536) Microorganisms panel - Urine sediment

312

1632

1.72

16.50

5.1

4.0

—

(3039000) Anion gap in Blood

119

444

2.37

16.30

4.3

5.4

11.71

11.43

mmol/l

0.29

107

395

(3018572) Chloride [Moles/volume] in Blood

119

444

2.37

16.30

4.3

5.4

104.53

105.12

mmol/l

0.69

107

395

(3040151) Glucose [Moles/volume] in Capillary blood

244

2.84

15.83

12.0

6.8

8.82

7.33

mmol/l

1.68

196

(3003338) MCHC [Mass/volume]

1788

13299

1.35

15.62

30.4

23.2

329.60

330.03

g/l

1.15

1732

13122

(3002582) Erythrocytes [#/volume] in Urine

967

6538

1.39

15.44

3.9

3.3

201.05

155.92

e6/l

0.16

797

5018

(3018095) Leukocytes [#/volume] in Urine

1062

7303

1.38

15.27

4.5

3.7

273.15

168.94

e6/l

0.87

845

5308

(3030981) Hyaline casts [#/volume] in Urine by Automated count

248

1255

1.77

14.71

4.1

2.8

0.59

0.42

e6/l

0.30

243

1236

(3006653) Thiamine [Moles/volume] in Blood

8.28

14.27

1.2

1.0

123.65

138.38

nmol/l

0.32

(3007853) Bacteria identified in Skin by Aerobe culture

357

2007

1.60

14.24

1.7

1.8

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

230

1154

1.78

14.05

1.6

2.2

404.84

399.90

nmol/l

0.14

186

1052

(3027273) Bicarbonate [Moles/volume] in Venous blood

239

1218

1.75

13.84

2.9

3.2

25.42

24.87

mmol/l

1.80

226

1182

(3002256) Pathology report gross observation

178

2689

0.55

13.61

1.4

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2337

18335

1.34

12.88

8.9

10.5

22.48

22.63

u/l

0.05

2098

17234

(3027945) Reticulocytes/100 erythrocytes in Blood

490

3027

1.47

12.60

2.3

2.2

1.74

1.72

0.19

372

2644

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1023

7161

1.34

12.58

2.6

2.8

170.25

173.33

ug/l

0.10

848

6343

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

196

974

1.79

12.38

1.7

1.8

2.57

2.43

ug/l

0.04

147

835

(3023183) Ammonium ion [Moles/volume] in Plasma

239

2.60

12.16

1.6

1.9

25.89

34.71

umol/l

2.68

182

(3004119) Hemoglobin [Mass/volume] in Venous blood

260

1412

1.64

11.90

2.8

3.0

128.67

124.85

g/l

1.94

252

1374

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

200

1013

1.75

11.84

2.2

2.3

0.71

0.66

1.32

191

977

(3026782) Osmolality of Urine

663

4376

1.39

11.75

3.5

2.8

546.41

550.46

mosm/kgh2o

0.22

580

3647

(3024354) Oxygen [Partial pressure] in Venous blood

308

1752

1.57

11.64

2.7

2.9

4.04

4.24

kpa

1.23

298

1691

(1616796) Gas panel - Central venous blood

107

461

2.04

10.42

3.6

3.7

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

3.73

10.41

2.5

2.3

—

(3025941) Bacteria identified in Stool by Culture

154

759

1.79

10.04

1.3

1.2

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

107

468

2.01

10.01

1.4

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

118

537

1.93

9.87

3.8

3.3

35.45

29.76

mg/l

0.94

366

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

278

2.30

9.69

1.4

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

3.78

9.67

1.4

1.9

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

3.78

9.67

1.4

1.9

—

(40757373) Influenza virus identified in Isolate

5.26

9.57

1.5

1.3

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

351

2148

1.46

9.38

2.8

3.3

5.91

5.79

kpa

1.17

338

2077

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

8.05

9.05

1.5

1.0

—

(3002032) Base excess in Venous blood by calculation

349

2154

1.45

8.91

2.8

3.3

1.97

1.85

mmol/l

0.22

278

1683

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

230

2.36

8.76

1.5

—

(40767503) Oxygen content in Capillary blood by calculation

434

1.96

8.57

2.4

2.5

15.78

15.27

0.59

220

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

428

4844

0.73

8.28

2.8

3.6

1.03

0.95

ug/l

0.28

309

3617

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

264

1565

1.50

8.27

2.4

3.4

98.65

101.20

ng/l

0.14

183

1283

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

435

1.93

8.19

1.4

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

180

983

1.62

8.11

3.9

4.0

1.65

1.51

1.91

167

929

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

282

1707

1.47

7.97

1.5

2.0

0.19

g/l

0.05

241

1555

(3027456) Digoxin [Moles/volume] in Serum or Plasma

150

790

1.67

7.80

3.7

3.2

0.82

0.81

nmol/l

0.06

114

603

(3014111) Lactate [Moles/volume] in Serum or Plasma

298

1833

1.45

7.75

3.0

5.4

1.60

1.36

mmol/l

2.57

278

1744

(3003694) ABO and Rh group [Type] in Blood

380

4336

0.73

7.70

1.3

—

(3022621) pH of Urine by Test strip

231

1363

1.50

7.42

4.2

3.5

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

609

4228

1.30

7.36

4.9

3.8

181.23

704.35

ng/l

4.97

559

3814

(3007930) Methemoglobin/Hemoglobin.total in Blood

176

980

1.58

7.34

3.9

4.0

0.94

0.85

2.35

164

924

(3014576) Chloride [Moles/volume] in Serum or Plasma

422

2783

1.36

7.29

3.8

5.7

104.06

104.41

mmol/l

0.70

386

2717

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

197

1131

1.54

7.19

3.9

6.1

24.53

24.69

mmol/l

0.21

190

1115

(36304419) Bacteria [Presence] in Urine

774

5588

1.26

6.77

3.6

3.2

—

(3000492) Spirometry study

1033

0.51

6.58

1.5

—

(40760892) CBC W Ordered Manual Differential panel - Blood

484

3310

1.31

6.50

3.5

4.2

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

229

2.13

6.39

1.4

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

7.22

6.36

1.0

—

(44806118)

180

2.28

6.28

1.6

1.3

—

(44790047)

180

2.28

6.28

1.6

1.3

—

(44790049)

180

2.28

6.28

1.6

1.3

—

(44790048)

180

2.28

6.28

1.6

1.3

—

(3026389) Candida sp identified in Specimen by Organism specific culture

181

2.26

6.21

1.3

1.4

—

(3019832) Treponema pallidum Ab [Presence] in Serum

209

2.17

6.20

1.1

1.2

—

(4034850)

100

504

1.74

6.17

12.3

11.2

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

182

2.25

6.13

1.3

1.4

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1120

0.55

6.12

1.3

1.2

—

(3009343) pH of Capillary blood

197

1172

1.48

6.12

2.7

3.7

7.42

0.18

154

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

198

1192

1.46

5.80

2.7

3.7

5.13

5.10

kpa

0.12

164

1072

(3044889) 12 lead EKG panel

1663

13114

1.19

5.79

4.8

4.4

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

188

2304

0.69

5.76

3.8

4.6

36.01

34.05

1.04

1288

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

189

1131

1.47

5.72

2.7

3.6

1.93

2.00

mmol/l

0.08

130

802

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

3.97

5.57

1.1

1.6

80.29

60.86

umol/l

—

(3020682) Albumin/Creatinine [Ratio] in Urine

663

6776

0.81

5.54

3.1

3.8

14.49

8.78

mg/mmol

1.81

406

4259

(3015235) Bicarbonate [Moles/volume] in Capillary blood

104

547

1.66

5.53

2.9

3.5

24.79

24.73

mmol/l

0.05

478

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

347

1.84

5.51

1.3

1.4

—

(3023520) Reticulocytes [#/volume] in Blood

342

2289

1.33

5.35

2.4

65.67

65.39

e9/l

0.05

257

1734

(3044242) Glucose [Moles/volume] in Arterial blood

122

2.42

5.29

1.3

2.0

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

240

2776

0.73

5.23

2.5

4.0

12.50

30.04

ug/l

1.68

189

2358

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

4.19

5.22

1.1

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

3.22

5.20

2.0

1.7

48.82

50.91

ug/l

0.08

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

3.75

5.19

1.1

1.3

19.18

17.14

pmol/l

0.47

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

419

1.73

5.15

1.1

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

421

1.72

5.07

1.1

—

(42529406) Shigella sp [Presence] in Stool by Culture

421

1.72

5.07

1.1

—

(3021589) Normoblasts [#/volume] in Blood

807

8028

0.83

5.07

11.8

10.0

0.00

e9/l

0.79

675

6449

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

3.83

5.00

1.1

1.0

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

349

2369

1.31

4.94

3.9

2.8

278.69

320.34

ng/l

0.89

322

2177

(3019977) pH of Arterial blood

154

2.20

4.92

1.4

2.2

7.43

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

933

0.57

4.76

1.8

3.1

34.11

4793.71

u/ml

2.28

797

(3012516) Albumin [Mass/volume] in Urine

623

6318

0.82

4.73

2.6

3.1

697.20

264.89

mg/l

1.07

387

3964

(3006270) Folate [Moles/volume] in Blood

163

2.14

4.69

1.1

1.2

241.94

298.09

nmol/l

0.84

116

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

158

1921

0.70

4.66

1.1

1.2

19.03

19.94

u/ml

0.04

625

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

5.10

4.63

1.0

1.1

—

(4094501)

377

0.34

4.56

1.1

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

476

1.63

4.51

2.2

2.3

125.55

122.19

g/l

0.74

353

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

263

1.86

4.46

1.4

1.3

—

(3009508) Creatinine [Moles/volume] in Urine

625

6302

0.82

4.44

2.5

3.0

6.73

6.65

mmol/l

0.20

476

5048

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

3.89

4.43

1.0

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

650

4801

1.21

4.41

2.5

2.9

33.10

37.95

u/l

0.97

590

4482

(3022948) Iron [Moles/volume] in Serum or Plasma

502

3618

1.24

4.33

2.2

2.4

10.56

11.65

umol/l

2.71

406

3322

(4027681)

7.80

4.32

1.1

1.5

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

456

1.63

4.27

1.2

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

3.57

4.27

1.0

—

(3011288) Drugs identified in Urine by Screen method

12.12

4.20

1.1

1.0

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

288

1.78

4.18

1.4

1.3

—

(3042936) Bacteria identified in Isolate by Culture

383

2692

1.26

4.13

1.8

—

(3013166) Neutrophils/100 leukocytes in Synovial fluid

2.89

3.99

1.1

1.7

73.91

62.84

0.67

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

180

1145

1.38

3.98

4.9

7.5

—

(3028707) Methadone [Presence] in Urine by Screen method

10.10

3.90

1.0

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

135

2.12

3.89

1.5

1.3

—

(3003181) Sodium [Moles/volume] in Urine

347

1.68

3.88

1.3

55.60

60.82

mmol/l

0.63

273

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

316

1.71

3.82

1.5

1.3

—

(40768795) Lymph node Pathology biopsy report

193

0.27

3.80

1.0

1.1

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

241

1.81

3.72

4.7

5.2

13.90

12.66

mg/l

0.73

217

(3021901) Oxygen saturation in Capillary blood

432

1.60

3.72

2.5

3.0

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

141

871

1.42

3.71

2.1

1.8

—

(3037522) Nuclear Ab [Titer] in Serum

133

1597

0.71

3.70

1.2

338.46

453.26

titre

0.57

371

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

2.74

3.64

1.0

1.4

—

(4281824)

203

0.30

3.63

1.0

1.1

—

(40768800) Prostate Pathology biopsy report

637

0.55

3.61

1.0

1.2

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

134

2.07

3.58

1.5

1.3

—

(3030467) Casts [#/volume] in Urine by Automated count

782

5974

1.17

3.56

3.6

3.2

0.52

0.58

e6/l

0.36

657

4504

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

130

798

1.42

3.56

2.1

1.7

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

764

0.59

3.54

2.0

4.3

186.98

82.63

u/ml

0.66

729

(3022145) Colonoscopy Study observation

155

1802

0.73

3.54

1.2

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

507

1.53

3.53

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

507

1.53

3.53

1.3

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

480

3516

1.21

3.52

1.5

2.01

1.91

mg/l

0.13

348

2763

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

208

1.84

3.50

1.9

1.4

20.69

23.00

u/ml

0.13

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

181

2051

0.75

3.49

1.1

1.2

55.98

51.60

iu/ml

0.10

631

(3003458) Phosphate [Moles/volume] in Serum or Plasma

376

2695

1.23

3.42

3.6

4.6

1.04

1.06

mmol/l

0.36

299

2427

(3021440) Promyelocytes/100 leukocytes in Blood

135

1588

0.72

3.34

3.7

3.5

0.12

0.08

0.25

479

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

2076

17045

1.14

3.29

4.5

5.1

6.28

6.13

mmol/l

3.52

1645

14626

(3024891) Influenza virus A+B Ag [Presence] in Specimen

365

1.60

3.25

1.2

—

(3002179) Metamyelocytes/100 leukocytes in Blood

126

1487

0.72

3.19

3.3

3.4

0.32

0.62

1.65

361

(40768797) Stomach Pathology biopsy report

205

2248

0.77

3.12

1.1

1.2

—

(3028626) Oxygen [Partial pressure] in Capillary blood

503

1.49

3.07

2.5

3.0

7.31

7.65

kpa

0.79

468

(3002385) Erythrocyte distribution width [Ratio]

1710

13902

1.13

3.06

25.2

20.9

14.22

14.10

2.55

1646

13480

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

119

741

1.40

3.06

2.9

3.2

4.16

4.30

pmol/l

0.70

637

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

1799

16419

0.88

3.03

21.1

16.8

63.94

65.30

ml/min/173m2

1.82

1344

13442

(3004588) Protein electrophoresis panel - Serum or Plasma

229

1575

1.28

3.01

2.1

2.4

—

(3000012) Reticulocyte production index

170

1.84

2.93

1.7

1.4

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

1276

10209

1.13

2.92

5.5

8.2

4.89

4.51

e9/l

4.07

1106

8677

(3010144) Erythrocytes [#/volume] in Synovial fluid

158

1.87

2.90

1.1

1.5

144123.43

112887.75

e6/l

0.11

124

(40768443) Skin Pathology biopsy report

857

0.66

2.86

1.1

1.2

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

5.51

2.84

1.3

1.2

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

1007

0.69

2.81

1.2

—

(4024509)

180

0.33

2.81

1.6

1.7

—

(3017181) Myelocytes/100 leukocytes in Blood

147

1658

0.76

2.79

3.8

3.5

0.75

0.79

0.08

505

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

193

1.76

2.75

2.7

2.3

—

(1617658) Protocol used for examination of sentinel lymph nodes

146

0.29

2.71

1.0

—

(3032057) Clostridioides difficile [Presence] in Stool

2.75

2.69

2.2

1.5

—

(3039443) Prostate specific Ag panel - Serum or Plasma

174

0.35

2.69

1.3

1.7

—

(3016879) Cocaine [Presence] in Urine

5.05

2.68

1.0

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

4.33

2.67

1.3

1.1

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

4.33

2.67

1.3

1.1

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1049

8329

1.13

2.67

4.5

6.0

9.10

5.23

ug/l

0.31

839

7252

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

1972

16248

1.12

2.64

6.7

6.6

43.77

41.15

mmol/mol

16.35

1638

14232

(3028300) Cannabinoids [Presence] in Urine

4.66

2.53

1.0

—

(3027944) Amphetamines [Presence] in Urine

4.66

2.53

1.0

—

(3027008) Opiates [Presence] in Urine

4.66

2.53

1.0

—

(3000764) Benzodiazepines [Presence] in Urine

4.66

2.53

1.0

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

3.54

2.48

1.1

1.0

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

2.74

2.47

1.0

1.3

—

(3033658) Prothrombin time (PT) actual/Normal

461

4548

0.86

2.45

3.3

3.7

76.82

79.53

1.36

438

4446

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

212

1486

1.25

2.43

3.1

2.9

56.26

54.51

ml/min/173m2

0.30

716

(1001926) Buprenorphine [Presence] in Urine by Screen method

5.19

2.40

1.0

—

(3025549) Creatine [Moles/time] in 24 hour Urine

4.33

2.40

1.1

1.4

—

(3037756) Immunofixation for Serum or Plasma

560

1.40

2.39

1.2

1.5

—

(3025159) Blasts/100 leukocytes in Blood

129

1444

0.76

2.36

3.6

3.4

0.02

0.27

1.54

381

(40768793) Breast Pathology biopsy report

334

0.51

2.35

1.2

1.3

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

3.65

2.32

2.1

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

198

1387

1.25

2.30

2.0

1.6

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

349

1.50

2.28

2.0

3.2

62.85

59.16

1.12

349

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

583

0.65

2.18

1.7

1.4

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

159

0.38

2.17

1.3

1.2

—

(1761868) Lipid panel - Serum or Plasma

425

4177

0.86

2.16

3.6

—

(3032773) Endomysium IgG Ab [Titer] in Serum

1.93

2.13

1.0

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

390

2940

1.17

2.10

2.5

2.6

0.81

0.82

mmol/l

0.43

341

2661

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

264

0.49

2.09

1.8

1.2

—

(3007164) IgA [Mass/volume] in Serum or Plasma

222

2299

0.82

2.09

1.6

1.5

2.99

2.90

g/l

0.10

111

1239

(3008295) Osmolality of Serum or Plasma

170

1.68

2.09

1.2

275.48

273.11

mosm/kgh2o

0.21

123

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

102

1156

0.76

2.08

4.6

7.2

23.86

24.31

mmol/l

0.51

1058

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

467

4538

0.87

2.03

2.3

2.5

—

(3024869) Neuronal Ab [Presence] in Serum

4.81

1.97

1.0

1.1

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

1088

0.76

1.97

1.4

1.2

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

610

0.68

1.97

1.6

2.2

0.00

g/l

0.00

554

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

255

0.51

1.91

2.3

1.8

13.36

369.43

u/ml

0.89

250

(3045716) Anion gap in Serum or Plasma

1.94

1.89

1.4

1.7

9.58

8.80

mmol/l

0.36

(3035933) Granulocytes/100 leukocytes in Blood

3.71

1.88

1.5

1.3

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

842

6721

1.11

1.88

4.4

5.1

21.42

22.83

1.84

422

3933

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

293

2926

0.85

1.85

2.8

3.8

252.33

251.53

u/l

0.04

245

2728

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

550

1.34

1.85

1.8

2.3

68.03

84.88

ug/min

0.21

301

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

3.19

1.84

2.3

2.1

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

444

3416

1.14

1.83

2.2

2.3

2.18

2.22

g/l

0.55

366

3127

(3004616) Nuclear Ab [Presence] in Serum

159

0.43

1.83

1.4

1.2

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

443

0.64

1.79

1.2

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

118

0.37

1.77

1.0

1.3

—

95.00

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

863

0.75

1.74

1.7

2.2

10.25

10.87

g/l

0.54

701

(3008536) Aspergillus sp Ab [Presence] in Serum

0.00

1.72

0.0

1.3

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

141

1.66

1.67

1.1

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

2.41

1.66

1.0

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

617

0.71

1.64

1.5

2.2

0.00

g/l

0.00

555

(3013115) Eosinophils [#/volume] in Blood

1091

8878

1.09

1.61

4.1

5.1

0.21

0.20

e9/l

0.53

924

7441

(3017704) Immunofixation for Urine

136

1.66

1.61

1.2

1.4

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

151

0.46

1.59

3.0

1.5

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

3.05

1.58

1.0

1.1

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

292

0.59

1.57

1.2

1.1

—

(3019198) Lymphocytes [#/volume] in Blood

1078

8782

1.09

1.55

4.1

5.1

1.66

1.88

e9/l

3.05

927

7393

(3020630) Protein [Mass/volume] in Serum or Plasma

262

1968

1.16

1.54

2.2

2.5

64.37

65.75

g/l

1.69

206

1732

(3000475) Leukocytes [#/volume] in Synovial fluid

418

1.35

1.52

1.4

1.7

42803.66

13417.40

e6/l

1.04

297

(3011412) CD3 cells [#/volume] in Blood

110

0.39

1.51

1.4

1.9

0.65

1.07

e9/l

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

156

1122

1.21

1.50

1.3

1.4

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

646

0.73

1.50

1.6

2.2

0.02

0.07

g/l

0.89

581

(3000991) Gas panel - Venous blood

237

1770

1.17

1.50

3.5

6.4

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

909

0.77

1.49

2.1

2.2

3.74

3.82

g/l

0.20

616

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

181

1.53

1.47

1.4

1.5

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

181

1.53

1.47

1.2

1.1

—

47.00

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

119

1256

0.81

1.43

1.5

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

912

0.78

1.42

2.1

2.2

7.44

7.75

g/l

0.55

640

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

911

0.78

1.41

2.1

2.2

—

(3006462) Nitrate [Presence] in Urine

108

1.69

1.41

5.9

4.0

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

262

1.42

1.40

1.3

—

(3051611) Lipemic interference index of Serum or Plasma

228

0.57

1.39

3.3

3.4

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

184

1.51

1.38

1.2

261.25

313.64

titre

—

(3008898) HLA-B27 [Presence]

183

0.52

1.38

1.0

—

(3044927) Protein electrophoresis panel - Urine

234

1.45

1.38

1.2

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

413

3227

1.12

1.37

2.4

19.77

21.26

1.19

274

2737

(3021879) Hepatitis B virus core Ab [Presence] in Serum

664

0.75

1.36

1.4

1.2

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

702

0.76

1.35

1.5

2.1

35.27

36.10

g/l

0.48

575

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

264

1.41

1.35

1.1

—

23.35

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

258

0.60

1.35

1.3

1.2

—

(3045414) Leukocytes [Presence] in Urine

711

0.76

1.34

2.8

2.0

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.60

1.33

1.0

1.1

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

658

1.26

1.33

3.0

4.1

24.68

24.55

mmol/l

0.12

571

(3035285) Chloride [Moles/volume] in Venous blood

399

1.33

1.31

2.7

2.5

107.03

105.18

mmol/l

1.11

394

(3041354) Potassium [Moles/volume] in Venous blood

399

1.33

1.31

2.7

2.5

4.13

4.18

mmol/l

0.45

394

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

124

1.61

1.31

2.6

1.8

1.33

2.99

u/field

0.59

(3020393) Adenovirus Ag [Presence] in Stool

2.88

1.31

1.0

—

(3035637) Corticotropin [Mass/volume] in Plasma

150

0.52

1.30

1.2

1.6

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

118

1.62

1.28

1.3

1.4

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

394

1.32

1.27

2.7

2.5

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

119

1.60

1.25

1.3

1.4

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

283

0.64

1.23

8.4

3.7

165.80

309.62

iu/ml

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

2.70

1.23

1.0

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

2.70

1.23

1.0

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

175

0.54

1.22

1.0

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

175

0.54

1.22

1.0

1.1

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

113

1.61

1.22

2.2

1.8

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

278

1.37

1.20

1.3

—

(3024263) Appearance of Synovial fluid

100

1.65

1.20

1.4

1.6

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

630

0.76

1.19

1.1

23.98

162.38

iu/ml

4.10

194

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

216

0.60

1.17

1.4

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

0.00

1.17

0.0

1.3

—

(3047189) Immunofixation for 24 hour Urine

113

0.46

1.17

1.3

1.5

—

(3014051) Protein [Presence] in Urine by Test strip

450

0.73

1.15

3.4

2.4

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.54

1.15

1.0

—

(4211845)

115

1.58

1.15

5.9

3.9

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

0.00

1.14

0.0

1.7

—

(3004809) Band form neutrophils/100 leukocytes in Blood

408

0.72

1.12

5.6

3.7

1.77

1.28

0.52

294

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

824

0.80

1.11

2.2

2.3

3.25

3.32

g/l

0.15

628

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

143

0.54

1.09

1.0

1.2

—

(3006315) Basophils [#/volume] in Blood

1047

8630

1.07

3.9

5.0

0.04

e9/l

1.32

898

7140

(3051593) INR in Capillary blood by Coagulation assay

1.64

1.07

9.4

30.5

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

914

0.82

1.06

2.0

2.4

0.38

0.33

u/ml

0.53

497

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

162

1611

0.86

1.06

2.1

2.3

30.18

35.93

u/l

1.74

128

1381

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

147

1.47

1.02

1.3

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.28

1.02

1.0

—

(3001604) Monocytes [#/volume] in Blood

1038

8568

1.07

1.01

4.0

5.0

0.63

0.65

e9/l

0.91

881

7080

(3000060) B lymphocytes [#/volume] in Blood

0.00

0.98

0.0

1.8

—

4041.82

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

0.00

0.98

0.0

1.0

—

10.16

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

0.00

0.98

0.0

8.0

—

5.35

—

(3045142) Bone marrow Pathology biopsy report

236

0.66

0.98

1.2

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

761

0.81

0.96

1.9

2.2

2.11

1.71

g/l

0.18

623

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

467

1.25

0.95

2.9

2.4

2.05

1.87

mg/l

0.79

402

(3026470) Cobalt [Mass/volume] in Blood

150

0.58

0.95

1.3

1.9

2.33

4.02

ug/l

—

132

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

520

0.78

0.93

1.7

2.6

582.11

1023.77

u/ml

0.44

481

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

127

0.54

0.93

1.1

1.3

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

127

0.54

0.93

1.1

1.3

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

1816

16112

0.94

0.93

3.9

4.5

1.40

1.45

mmol/l

3.91

1451

13860

(3012441) Differential panel - Pleural fluid

381

0.75

0.90

1.3

1.5

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

389

0.75

0.88

1.4

12.41

12.75

mg/l

0.06

352

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

157

0.60

0.88

1.3

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

160

1.41

0.87

1.1

1.5

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

167

0.62

0.87

1.3

—

(3001729) Color of Synovial fluid

2.00

0.86

1.2

2.0

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

2.00

0.86

2.3

4.3

—

(3044941) Cell count panel - Synovial fluid

288

1.29

0.86

1.3

1.4

—

(3045424) Erythrocytes [Presence] in Urine

218

0.67

0.85

1.5

1.3

—

(3022313) Gas panel - Capillary blood

112

833

1.17

0.84

2.8

3.8

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

1.68

0.84

2.5

2.6

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

550

0.80

0.84

1.5

31.87

37.27

u/l

0.81

447

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

154

1.41

0.84

1.1

1.5

—

(3048879) Bone marrow aspiration report

0.52

0.83

1.0

1.4

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

468

1.22

0.83

1.2

1.4

248.56

258.19

ug/g

0.15

297

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

257

0.70

0.83

3.6

—

(3013727) Leukocytes other/100 leukocytes in Blood

1.59

0.83

8.7

3.1

55.04

58.08

0.19

(3018010) Neutrophils/100 leukocytes in Blood

908

8196

0.94

0.82

4.6

5.3

61.20

59.95

1.98

804

7472

(3016038) Potassium [Moles/volume] in Urine

133

1.43

0.82

1.0

1.1

32.01

37.20

mmol/l

0.60

105

(3000285) Sodium [Moles/volume] in Blood

1.73

0.81

1.3

—

(4010399)

111

1108

0.86

0.81

1.4

—

(3045788) Cell count panel - Pleural fluid

344

0.75

0.80

1.3

1.5

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

412

0.77

0.80

1.4

120.25

4.33

iu/ml

—

121

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

0.00

0.79

0.0

1.0

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

781

0.84

0.79

1.2

1.6

—

14.74

—

(3010375) cycloSPORINE [Mass/volume] in Blood

1.69

0.79

25.6

27.4

97.25

109.81

ug/l

—

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

0.00

0.77

0.0

1.2

—

9.33

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

2.16

0.76

1.0

1.1

—

1.64

—

(3034770) Mitochondria Ab [Titer] in Serum

320

0.75

0.74

1.0

1.1

—

1253.33

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

181

1.34

0.73

1.1

1.4

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

181

1.34

0.73

1.1

1.4

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

181

1.34

0.73

1.1

1.4

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

1753

15505

0.95

0.73

3.6

4.0

1.22

1.20

mmol/l

0.60

1376

13158

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

613

1.17

0.71

1.9

1.7

—

(3004451) EKG impression Narrative

108

1.44

0.71

1.2

1.3

—

(3013512) EKG study

758

6269

1.06

0.70

4.5

4.4

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1023

8531

1.05

0.70

4.4

4.3

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

402

0.79

0.69

1.3

1.5

97519.77

41055.90

e6/l

0.57

235

(3000330) Specific gravity of Urine by Test strip

141

1363

0.89

0.68

5.0

3.9

—

(40760888) Immunoglobulin light chains.free panel - Serum

673

1.16

0.67

3.0

3.2

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

0.53

0.67

1.0

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

1.64

0.67

1.7

1.5

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

135

0.64

0.67

1.3

1.1

—

47.92

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

0.52

0.66

1.4

2.1

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

1.80

0.66

1.2

1.0

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

1.59

0.66

1.1

—

(3005719) IgG [Mass/volume] in Serum or Plasma

108

1059

0.88

0.65

2.9

2.7

11.65

11.09

g/l

0.35

958

(3025577) Chromium [Mass/volume] in Blood

144

0.66

0.64

1.4

1.9

2.11

ug/l

0.00

121

(3036489) Thrombin time

397

1.20

0.63

1.6

1.8

21.82

23.12

0.78

350

(40761539) Cells [Type] in Urine sediment by Light microscopy

1.56

0.62

1.1

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

249

1.25

0.61

2.8

2.2

2.57

1.81

u/field

0.27

(3019897) Erythrocyte distribution width [Ratio] by Automated count

1.66

0.61

12.8

6.8

14.02

13.93

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

0.00

0.61

0.0

1.1

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

0.00

0.61

0.0

1.4

—

68.54

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

0.00

0.61

0.0

1.0

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

0.00

0.60

0.0

4.3

—

71.00

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

1.51

0.59

1.2

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

0.00

0.59

0.0

2.0

—

72.27

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

0.00

0.59

0.0

1.0

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

113

1.38

0.58

6.8

3.0

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

136

1303

0.90

0.58

1.8

1.6

1.65

1.57

g/l

0.44

101

1105

(3048689) Calprotectin [Mass/mass] in Stool

135

1293

0.90

0.58

1.6

1.8

288.98

158.58

ug/g

1.00

970

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

383

3502

0.94

0.56

3.6

3.0

2.30

2.67

e6/l

0.43

217

2025

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

175

1.29

0.55

1.2

1.5

14.17

31.11

3.26

110

(3003434) Protein [Mass/volume] in Pleural fluid

502

0.84

0.55

1.3

1.5

29.81

31.14

g/l

0.36

448

(3017446) Testosterone [Moles/volume] in Serum or Plasma

102

989

0.89

0.55

1.8

1.9

8.91

9.39

nmol/l

0.21

820

(3028026) IgM [Mass/volume] in Serum or Plasma

879

0.88

0.54

1.9

1.03

1.55

g/l

1.71

769

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

245

1971

1.08

0.54

2.2

2.5

9.43

12.08

umol/l

0.73

187

1710

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

443

0.84

0.52

1.8

1.6

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

247

1.23

0.52

7.0

3.9

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

0.60

0.52

1.0

1.1

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

312

2539

1.07

0.51

1.2

1.32

2.18

u/ml

1.18

586

(3006504) Eosinophils/100 leukocytes in Blood

920

8201

0.96

0.51

4.6

5.3

2.74

2.79

0.19

814

7475

(3035320) C reactive protein [Mass/volume] in Body fluid

136

0.70

0.51

3.9

2.5

—

(3005570) Glucose [Moles/volume] in Urine

209

1.24

0.50

3.4

1.9

—

(3023199) Leukocytes [#/volume] in Pleural fluid

440

0.84

0.49

1.3

1.5

2226.12

1493.01

e6/l

0.85

315

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

393

0.83

0.49

1.3

1.2

39.27

52.52

u/l

0.32

330

(3008116) Ketones [Moles/volume] in Urine by Test strip

1.55

0.49

1.4

1.1

—

(40768806) Pleura Pathology biopsy report

374

0.83

0.49

1.5

1.6

—

(4306422)

0.63

0.48

1.1

1.3

—

(1002224) Polysomnography panel

1.41

0.48

1.0

1.1

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

110

1.34

0.48

1.1

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

1.51

0.48

1.0

1.1

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

156

1.28

0.48

1.4

1.3

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

1.44

0.46

1.1

—

(21494434) Karyotype in Bone marrow

230

0.79

0.46

1.0

1.1

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

201

0.77

0.46

1.3

1.2

—

(3019069) Monocytes/100 leukocytes in Blood

927

8240

0.96

0.45

4.9

5.5

9.14

9.04

0.32

823

7531

(4146454)

229

0.79

0.45

2.2

2.8

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

1.36

0.44

1.6

1.3

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

1.36

0.44

1.6

1.3

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

1.38

0.44

2.3

1.1

—

(40758558) Short blood count panel - Blood

495

4455

0.95

0.43

4.8

6.5

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

496

1.14

0.42

1.2

1.4

—

(3008037) Lactate [Moles/volume] in Venous blood

685

1.11

0.42

3.7

3.4

1.79

1.67

mmol/l

0.72

673

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

1865

16354

0.97

0.42

3.9

4.5

4.13

4.36

mmol/l

16.08

1511

14219

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

359

1.16

0.41

1.2

—

(3015956) Eosinophils/100 leukocytes in Blood by Manual count

0.00

0.41

0.0

2.0

—

1.31

—

(3009871) Measles virus Ab [Titer] in Serum

0.00

0.41

0.0

1.8

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

0.00

0.41

0.0

1.0

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

123

976

1.09

0.41

2.6

3.4

23.94

24.04

mmol/l

0.12

107

883

(3014891) Appearance of Pleural fluid

1.36

0.41

1.5

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

0.00

0.41

0.0

1.1

—

(3019225) pH of Specimen

250

2042

1.06

0.40

4.6

4.0

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

0.00

0.40

0.0

1.3

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

1943

17015

0.97

0.39

4.4

5.2

2.28

2.51

mmol/l

23.15

1576

14704

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

1.39

0.38

1.8

2.1

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

100

0.69

0.37

1.3

1.2

—

(3051651) Icteric interference index of Serum or Plasma

105

0.74

0.35

2.8

3.6

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

174

0.79

0.35

1.2

1.7

4.56

5.05

mg/l

0.13

161

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

174

0.79

0.35

1.2

1.1

—

46.67

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

293

1.15

0.34

1.8

1.5

3.28

4.71

iu/l

0.75

(3020779) Urea [Moles/volume] in Serum or Plasma

244

2006

1.06

0.33

4.2

5.1

12.55

13.09

mmol/l

0.42

210

1851

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

144

0.78

0.33

1.1

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

219

0.83

0.33

1.3

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

1.30

0.33

1.0

1.1

—

(3005322) IgE [Units/volume] in Serum or Plasma

590

1.10

0.32

1.1

1.2

308.45

249.26

u/ml

0.34

528

(3042631) Mycobacterium sp identified in Specimen

366

0.87

0.32

2.4

2.7

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

114

0.76

0.31

1.1

1.0

—

(3022096) Basophils/100 leukocytes in Blood

906

7997

0.97

0.30

4.6

5.3

0.55

0.62

3.11

803

7296

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

215

0.84

0.28

1.3

1.2

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

215

0.84

0.28

1.3

1.2

—

(3002030) Lymphocytes/100 leukocytes in Blood

951

8376

0.97

0.28

4.8

5.5

23.21

24.65

3.18

840

7595

(3038515) Glucose [Moles/volume] in Venous blood

663

1.08

0.27

3.8

3.5

8.88

7.72

mmol/l

2.05

650

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

121

0.79

0.27

1.0

1.1

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

101

0.77

0.27

1.0

1.1

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

214

0.85

0.27

1.3

1.2

—

(3023419) Bacteria identified in Sputum by Culture

260

0.86

0.27

1.7

2.5

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

1.21

0.27

1.0

1.1

—

(3049717) Cytology report of Urine Cyto stain

136

1109

1.06

0.27

2.9

3.2

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

278

0.87

0.27

2.2

2.0

50.43

28.42

mg/l

—

(3024928) Oxygen saturation in Venous blood

423

0.90

0.26

1.6

2.4

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

120

0.79

0.26

1.0

1.1

—

1.73

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

213

0.85

0.26

1.3

1.2

—

(3043410) Blood group antigens tested for on Red Blood Cells

0.66

0.26

1.6

1.5

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

203

0.85

0.25

1.1

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

212

0.86

0.25

1.3

1.2

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

119

0.80

0.25

1.2

—

(3017569) Oxygen content in Arterial blood

119

0.80

0.25

1.5

2.1

—

(3000494) Fungus identified in Specimen by Culture

190

1717

0.95

0.24

1.4

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

104

845

1.07

0.24

3.0

3.1

6.37

3.53

ratio

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

0.76

0.22

1.0

1.5

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

0.76

0.22

1.0

1.5

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

0.75

0.22

1.3

1.5

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

1.27

0.22

1.5

3.7

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

100

1.21

0.22

1.2

1.3

4.59

163.06

ug/l

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

0.00

0.21

0.0

1.8

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

0.00

0.21

0.0

1.8

—

(40758358) Immune stain study

0.00

0.21

0.0

1.0

—

(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.21

0.0

1.9

—

20.42

—

(44806071)

0.00

0.21

0.0

1.1

—

(3049242) von Willebrand panel - Platelet poor plasma

0.00

0.21

0.0

3.0

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.2

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

0.00

0.21

0.0

1.0

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

515

0.92

0.21

1.0

—

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

0.00

0.21

0.0

1.2

—

104.18

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

0.00

0.21

0.0

1.2

—

(3025315) Body weight

0.00

0.20

0.0

6.1

—

(3007916) DNA double strand Ab [Titer] in Serum

0.00

0.20

0.0

1.1

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

0.00

0.20

0.0

1.0

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

0.00

0.20

0.0

1.2

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

0.00

0.20

0.0

1.3

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

0.00

0.20

0.0

4.0

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

0.00

0.20

0.0

1.0

—

(40758292) HTLV I+II Ab panel - Serum

0.00

0.20

0.0

1.3

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

1.27

0.20

1.3

3.0

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

1.27

0.20

1.0

1.1

—

(1761482) Bacteria [#/volume] in Urine by Culture

107

877

1.06

0.20

5.4

4.3

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

120

987

1.05

0.20

1.4

1.3

—

(3021788) Differential panel - Synovial fluid

333

0.91

0.19

1.3

1.4

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

283

1.10

0.18

1.2

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

1.21

0.18

7.2

6.8

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

151

0.86

0.18

3.3

3.5

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

160

0.86

0.18

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

0.71

0.17

1.0

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

0.71

0.17

1.0

—

(3044007) Cell count panel - Peritoneal fluid

0.71

0.17

2.0

1.5

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

0.71

0.17

1.0

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

0.71

0.17

1.0

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

0.71

0.17

1.0

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

0.71

0.17

1.0

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

1.17

0.16

1.6

1.1

5.96

6.79

mmol/l

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

1.13

0.16

2.4

1.8

19.51

37.04

u/l

—

(3017732) Neutrophils [#/volume] in Blood

124

1029

1.04

0.16

3.2

2.9

4.84

4.58

e9/l

0.30

674

(40765096) Chromosome analysis panel by Banding

0.79

0.15

1.2

1.1

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

0.79

0.15

1.2

1.3

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

0.79

0.15

1.2

1.3

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

117

1054

0.96

0.15

1.3

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

0.75

0.15

1.7

2.2

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

166

0.88

0.14

1.1

—

(3037121) Protein [Mass/volume] in Urine

704

1.04

0.12

2.8

2.9

0.37

0.34

g/l

0.11

288

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

206

1.09

0.12

1.2

1.5

78.87

61.75

2.12

132

(3034860) Kappa light chains.free [Mass/volume] in Serum

105

875

1.04

0.12

3.0

3.1

61.77

135.84

mg/l

0.58

708

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

100

0.86

0.11

1.4

1.6

3.40

7.35

u/l

—

(3002523) Influenza virus A Ag [Presence] in Specimen

1.11

0.10

1.0

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

1.11

0.10

1.0

1.1

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

1.08

0.09

1.2

1.1

—

50.92

—

(3022689) Creatine [Moles/volume] in Urine

1.05

0.09

1.4

1.6

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

404

1.05

0.09

1.5

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

223

0.93

0.09

1.1

1.2

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

104

874

1.03

0.08

3.0

3.1

32.82

60.89

mg/l

2.48

714

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

346

0.95

0.08

1.2

1.3

402.45

478.96

u/l

0.18

335

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

1.04

0.08

4.0

1.7

—

(3011648) Oxygen content in Venous blood

126

1.10

0.08

1.3

1.5

10.59

10.58

0.00

126

(3037692) Legionella sp identified in Specimen by Organism specific culture

0.81

0.07

2.7

1.3

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

177

0.93

0.07

1.1

1.0

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

265

0.95

0.07

1.3

1.13

0.73

nmol/l

0.50

216

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

344

0.95

0.07

2.9

2.6

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

159

0.92

0.07

1.1

351.67

265.61

u/ml

0.45

(3009214) Lutropin [Units/volume] in Serum or Plasma

141

0.92

0.07

1.2

1.3

13.93

13.31

u/l

—

107

(21494890) Protein electrophoresis panel - 24 hour Urine

255

1.05

0.06

2.4

2.2

—

(3026493) Urate [Moles/volume] in Serum or Plasma

579

4969

1.01

0.06

2.6

2.9

2562.46

9172.04

umol/l

4.38

430

4098

(3035880) pH of Pleural fluid

196

1.06

0.06

1.2

1.3

—

(3003327) Ova and parasites identified in Stool by Light microscopy

341

1.04

0.06

1.7

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

175

0.94

0.05

1.1

—

(3036782) Glucose [Moles/volume] in Pleural fluid

324

0.96

0.05

1.3

1.4

6.51

6.36

mmol/l

0.12

305

(3042111) Morphology [Interpretation] in Bone marrow Narrative

446

0.97

0.05

1.4

1.3

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

130

0.93

0.04

1.4

1.1

—

(3044640) Blood type and Crossmatch panel - Blood

708

6092

1.01

0.04

2.4

2.6

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

129

0.94

0.03

1.1

1.2

—

(3000919) Neutrophils/100 leukocytes in Pleural fluid

114

1.06

0.02

1.1

1.5

21.86

15.50

0.33

100

(3020491) Glucose [Moles/volume] in Blood

128

0.95

0.02

1.6

3.5

7.48

7.34

mmol/l

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

1.08

0.02

1.1

1.4

45.40

66.58

mg/l

—

(3000034) Microalbumin [Mass/volume] in Urine

183

1.04

0.02

2.5

3.1

44.21

29.09

mg/l

0.25

144

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

426

3668

1.00

0.02

3.0

2.9

1.59

1.33

e6/l

0.89

258

2178

(3004775) Volume in Urine collected for unspecified duration

206

0.96

0.02

1.6

2.0

491.20

677.89

—

122

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

614

1.01

0.02

1.4

1.5

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

118

0.95

0.01

1.3

1.1

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

0.98

0.00

1.6

1.5

163.60

184.40

pmol/l

—

(4062490)

101

1.03

0.00

1.2

—

(3000093) Morphology [Interpretation] in Blood Narrative

207

1.00

0.00

1.1

—

(44806420)

120

1.01

0.00

2.2

2.6

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

177

1.03

0.00

1.0

1.2

57.00

67.57

u/l

0.28

118

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

184

0.99

0.00

1.5

1.2

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

150

1292

1.00

0.00

2.3

2.5

—

(3052851) Hemolysis interference index of Serum or Plasma

606

1.00

0.00

3.1

3.6

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

272

1.02

0.00

1.2

1.3

26.68

12.99

u/l

0.47

260

(42870588) Differential panel, method unspecified - Blood

704

6090

1.00

0.00

4.3

5.2

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

331

0.99

0.00

1.7

1.6

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

200

0.99

0.00

1.2

—

(36660697) Celiac disease serology panel - Serum

100

864

1.00

0.00

1.3

1.2

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

584

0.99

0.00

1.9

1.6

108.00

236.97

titre

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

852

1.00

0.00

2.6

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

109

1.03

0.00

1.1

1.4

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

109

1.03

0.00

1.1

1.4

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

109

1.03

0.00

1.1

1.4

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

109

1.03

0.00

1.1

1.4

—

(3023436) Glucagon [Mass/volume] in Serum or Plasma

0.00

0.0

2.9

—

277.29

—

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

0.00

0.0

2.4

—

3.38

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

0.00

0.0

1.6

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

0.00

0.0

1.0

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

0.00

0.0

1.0

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

0.94

0.00

1.2

—

(3011897) Casein IgE Ab [Units/volume] in Serum

0.00

0.0

1.2

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

0.00

0.0

15.3

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

0.0

1.0

—

(3005033) Fetal Nuchal fold Thickness US

0.00

0.0

1.6

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

0.00

0.0

2.7

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

0.00

0.0

1.6

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

0.00

0.0

1.0

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

0.00

0.0

1.6

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

0.00

0.0

11.3

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

0.88

0.00

1.3

17.43

15.86

umol/l

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

0.00

0.0

1.6

—

(3032868) Hemoglobin electrophoresis panel in Blood

0.00

0.0

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

0.00

0.0

1.6

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

0.00

0.0

1.0

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

0.00

0.0

1.0

—

1214.00

—

(21494671) JAK2 gene exon 14 targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

0.0

1.0

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

0.00

0.0

1.6

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

0.92

0.00

1.1

1.3

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

0.00

0.0

1.6

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

0.00

0.0

1.6

—

(3033799) Differential panel - Peritoneal fluid

0.98

0.00

1.3

1.7

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

0.00

0.0

1.0

—

(3022475) Manganese [Moles/volume] in Blood

0.00

-0.00

0.0

1.5

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.2

—

Mortality – FinRegistry

↥

Association

Association between endpoint AD_AM_EXMORE and mortality.

Females

Parameter	HR [95% CI]	p-value
AD_AM_EXMORE	2.457 [2.15, 2.8]	< 0.001
Birth year	0.994 [0.99, 1.0]	0.115

During the follow-up period (1.1.1998 — 31.12.2019), 14195 out of 22026 females with AD_AM_EXMORE died.

Males

Parameter	HR [95% CI]	p-value
AD_AM_EXMORE	2.861 [2.4, 3.41]	< 0.001
Birth year	0.987 [0.98, 1.0]	0.004

During the follow-up period (1.1.1998 — 31.12.2019), 9194 out of 13609 males with AD_AM_EXMORE died.

Mortality risk

Mortality risk for people of age

years, who have AD_AM_EXMORE.

N-year risk	Females	Males
1	0.236%	0.516%
5	1.387%	2.993%
10	3.512%	7.569%
15	6.285%	14.062%
20	10.835%	22.816%

Relationships between endpoints

↥

Index endpoint: AD_AM_EXMORE – Alzheimer’s disease (Atypical or mixed), excluding more controls

GWS hits: 4

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Alzheimer’s disease (Atypical or mixed), excluding more controls

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints